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Transcription from the Rous sarcoma virus (RSV) Long terminal repeat (LTR) in
untransformed rat 3Yl fibroblasts is dependent on the presence of serum. Within an
hour of addition of serum to a serum-deprived culture there is a 5 fold stimulation in the
level of transcripts initiated at the LTR. This stimulation does not require synthesis of
new proteins. Mutations in the RSV LTR revealed that serum-stimulated transcription
was mostly dependent on two CCAAT boxes in the LTR, though other upstream
sequences may play a secondary role. Serum caused the rapid appearance of a nuclear
protein that binds to the two CCAAT boxes. This serum-induced CCAAT factor was
also bound by CCAAT sequences from other promoters, e.g. those of human heat shock
protein 70, human c-Ha-ras, human histone 1 etc, but not by the adenovirus origin of
replication, or the SV40 enhancer core sequence. This data suggests that the serum
induced CCAAT factor is related to CPl or CP2 rather than the NFl or CjEBP types
of CCAAT binding factors. The abundance of the factor in the nucleus is increased by
serum even in the presence of inhibitors of new protein synthesis.
The serum dependence of transcription from the RSV LTR is lost in v-src
transformed 3Yl, and cross-feeding experiments showed that the mechanism did not
involve the production of extra-cellular growth factors. Temperature-sensitive (ts) v-src
transformed 3Yl was used to demonstrate that the tyrosine kinase activity of v-src can
(a) substitute for the serum-requirement of the RSV LTR, (b) increase the level of tran­
scripts initiated in the LTR even in the presence of serum, (c) exert its serum-sparing
effect on the RSV LTR in the absence of new protein synthesis, and (d) increase the
amount of CCAAT binding factor in the nucleus. Orthovanadate, an inhibitor of
tyrosine-phosphatases, which non-specifically elevates the level of phosphotyrosine in the
cells, can mimic the effects of serum and v-src on transcription from the RSV L TR.
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The RSV LTR directed accurate initiation of transcripts in Saccharomyces cerev­
isiae, about 60 bases downstream from the TATA box that is used in animal cells.
Mutations in the LTR revealed that the authentic TATA box was absolutely necessary
for the transcription, and the CCAAT boxes that are responsive to serum in animal
cells, were acting as "upstream activating sequences". The absence of the TATA box or
the CCAAT boxes gave a phenotype to the yeast carrying the mutant derivatives of
RSVCAT, making it possible to establish a genetic system for cloning genes for yeast
and mammalian transcription factors, and do structure-function analysis on them. The
activity of the RSV LTR in yeast is not stimulated by la.ctate, and is not decreased by
mutations in the HAP2 or HAP3 genes, suggesting that the "UAS" activity of the
CCAAT boxes is mediated by yeast CCAAT binding factors other than HAP2/HAP3.
While a high level of V-STC is toxic to the yeast, expression of very low levels of the
oncogene may be stimulating the CAT activity from the RSV LTR about two fold. If
this can be seen at the phenotypic level, it may be possible to establish a genetic system'




Two approaches to studying transformation of cells by V-STC.
Transformation of cells in culture by Rous sarcoma virus has been extensively stu­
died as a model for understanding the mechanism of carcinogenesis (Hanafusa, 1977).
This has given us tremendous insight into how normal cellular genes can be picked up
by retroviruses and be converted into viral oncogenes. It turns out that the mechanism
of this conversion itself gives a clue as to how the oncogene transforms cells. In the case
of C-STC, transduction into a retrovirus itself involved truncation of a C-terminal regula­
tory region (Lerner et al., 1984; Dutta et al., 1985), followed by multiple mutations in
the rest of the gene. All of these changes presumably increase the tyrosine kinase
activity of the oncogene and result in the transforming phenotype (reviewed in Jove and
Hanafusa, 1988; Wang and Hanafusa, 1988).
The minimal requirement for transformation has been studied extensively by in
vitro mutagenesis of both v- and c- STC. Transformation requires (a) an elevated tyro­
sine kinase activity achieved by the mutations referred to above and by the linkage of
the STC gene to a strong promoter (Jacobovits et al., 1984) and (b) a membrane anchor­
ing myristylation signal that directs the V-STC protein to the plasma membrane presum­
ably to phosphorylate critical substrates in that subcellular fraction (Cross et al., 1984;
Pellman et al., 1985a, 1985b). However, though mutagenesis of V-STC is very effective in
defining domains of the protein required for transformation it can only lead to some edu­
cated guesses as to how those domains contribute to the phenotype.
Since the tyrosine kinase activity is absolutely essential for transformation, one
approach stemming from the "educated guesses" has been to catalogue the phosphotyro­
sine containing proteins in the transformed cell. Defining the path way to the
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transformed phenotype from v-src by this approach, however, is currently stymied by
the large number of cellular proteins that are phosphorylated on tyrosine in v-src
transformed cells (Hamaguchi et al., 1988).
The second approach is to select a particular phenotype seen in the transformed
cell, define it in molecular terms and work backwards from there to the tyrosine kinase
activity of v-src, Such a strategy has indeed been taken in studying the decreased
adhesiveness of transformed cells. Studies by several groups have led to elucidation of
the diminished secretion of fibronectin and the decreased affinity of the fibronectin recep­
tor for fibronectin in the transformed cell (Plantefaber and Hynes, 1989; and references
therein).
Looking around for a thesis project, I opted for the latter approach. I wanted to
define one parameter of the transformed cell in molecular terms and then try to work
backwards from there to v-src,
Why does an avian retrovirus pick up a cellular oncogene?
Over the decades many retroviruses have been studied, and it is rather peculiar
that whenever a cellular gene is transduced into a retrovirus, it always appear to be an
oncogene. One possible reason is selection imposed by the observer, given that most of
the retroviruses under scrutiny used to be studied because of their "cancer inducing"
properties. However, the situation changed with the appearance of human retroviruses
and yet there do not appear to be naturally occurring retroviruses that have picked up a
cellular "non-oncogene".
Another observation that may be of interest, is the frequent loss of a non­
transforming, in vitro created mutant of an oncogene from a retrovirus, when it is pas­
saged in culture (Foster D. A., personal communication; long S.-M. and L.-H. Wang,
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personal communication). Finally, if non-transforming cellular genes can be passaged in
a retrovirus, there is the frequent appearance of mutants that have activated the
transforming ability of the gene (Iba et al., 1984; Levy et al., 1986; Hanafusa T., personal
communication; Wang L.-H., personal communication).
Considering all of the above, it could .be hypothesised that the cellular oncogene is
transduced into the retrovirus and converted into a transforming viral oncogene because
it aids the virus in some way. Temin (1967a) and Humphries and Temin (1972 and
1974) showed that RSV could infect a cell and not produce viral particles unless the cell
passes through mitosis at least once. It could therefore be suggested that the virus picks
up an oncogene because it forces the cell through mitosis and initiates viral replication.
However, it is possible that transformation by the oncogene, v-src, influences viral repli­
cation not only at the beginning of virus production but in a more continuous manner
well after the initial production. In fact, to be of interest as a phenotype in the
transformed cell that could be studied in molecular terms and would lead back to v-sr c,
it would have to be an effect that is seen well after virus production has started, when
the cell has a full-blown transformed phenotype. Is there such an effect of v-src on viral
replication?
The question can be rephrased as : if there is such an effect on VIrus replication,
where does one look for it? There are several steps in the viral replication cycle that
take place continuously in the transformed cell. Specifically, these are transcription of
genomic and subgenomic viral RNA, translation of viral proteins, assembly of viral parti­
cles and finally their release. Of these, the more easily studied steps clearly relate to the
transcription, processing and translation of viral genes. Since most of the viral tran­
scription signals are located in about 400 bp of viral sequence called the "long terminal
repeats" (LTR), it seemed prudent to address the issue of viral transcription.
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We have discovered that transcription from the RSV LTR is dependent on the
presence of serum, and that v-src relieves this serum-dependence.
Oncogenes and transcription.
Oncogenes usurp normal cellular pathways of growth control. There are oncogenes
that resemble peptide growth factors, e.g. v-sis is the PDGF B chain (Waterfield et al.,
1983; Doolittle et al., 1983), and others that resemble peptide growth factor receptors
with tyrosine kinase activity, e.g. v-erbB is derived from the EGF receptor (Downward
et al., 1984), c-fms from the CSF-l receptor (Sherr et al., 1985). Some oncogenes appear
to transduce signals from cell surface receptors to other proteins on the inner side of the
plasma membrane, e.g. ras (Masters and Bourne, 1986) and a cytoplasmic tyrosine
kinase protein belonging to the src family called lck (Veillete et al., 1988). Several other
oncogenes have been found to be transcription factors themselves, e.g. c-jun and API
(Bohmann et aI., 1987), c- erbA and the thyroid hormone receptor (Sap et al., 1986;
Weinberger et aI., 1986).
A large number of oncogenes may be acting by associating with and activating
some of the proteins on the signal transduction pathway. Examples would include
polyoma middle T and its association and activation of the src family of cytoplasmic
tyrosine kinases (Courtneidge and Smith, 1983; Kornbluth et aI., 1987; Cheng et al.,
1988; Kypta et al., 1988) and v-crk and its association with unknown cellular proteins
resulting in the activation of cellular tyrosine kinases (Mayer et al., 1988). Oncogenes
may act by associating with known transcription factors, e.g. the association of c-fos and
API (Rauscher III et al., 1988). Oncogenes from DNA tumor viruses have been found to
associate with and presumably alter the function of nuclear DNA binding proteins, e.g.
the association of SV40 large T and adenovirus E1A, with the retinoblastoma gene pro-
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duct, itself an "anti-oncogene" (DeCaprio et al., 1988; Whyte et al, 1988).
Overexpression of several genes involved in normal signal transduction pathways to
the transcriptional apparatus have been found to confer some of the phenotypes of
transformed cells. Examples include overexpression of the CSF 1 gene and its receptor
(Roussel et al., 1987;), of the basic fibroblast growth factor (Rogelj et al., 1988), of the
insulin receptor (Wang L.-H., personal communication), and of protein kinase C (Housey
et al., 1988). This too suggests that most oncogenes transform cells by using normal sig­
nal transduction pathways, and further implies that once some of the critical genes
involved in the pathway are themselves induced, they may perpetuate the transformed
phenotype.
In fact, considerable advances have been made in discovering various genes that are
turned on by transformation, and several of them turn out to be induced in normal cells
in response to normal growth signals (Sugano et al., 1987; Bedard et al., 1987; Anisowicz
et al., 1987; Ryder et al., 1988; Simmons et al., 1989). It is because of these precedents
that we devoted much of our effort to understanding how serum induces expression from
the RSV LTR in the hope that v-src would utilize similar pathways to turn on the same
LTR (Chapter 2).
Once the RSV LTR was shown to be responsive to a normal growth stimulus,
namely serum, we could define sequence elements in the LTR that are responsible for the
induction by serum, demonstrate the presence of a nuclear factor that binds to these ele­
ments, and demonstrate the serum-induction of this factor. The factor turned out to be
a known transcription factor, though it was not known that it was responsive to growth
signals. Further, we could show (Chapter 3) that v-src also stimulates expression from
the RSV LTR and induces the same serum-responsive transcription factor, setting the
stage for subsequent research into the mechanism of induction of this factor by v-src.
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A genetic system for studying transcription from the RSV LTR and the effects
of v-src on it.
The study of substrates for v-src has been limited to biochemical approaches due to
the absence of genetic tools that can be used easily in animal cells. Encouraged by the
significant advances that have been made in the study of transcription of eukaryotic
genes by an effective blend of biochemical purification of transcription factors from
animal cells and genetic identification of analogous activities in yeast (Wingender, 1988;
Jones et al., 1988; Ptashne, 1988), we attempted to transfer the v-src and its effect on
the RSV LTR into S. cerevisiae in an effort to establish a genetically tractable system for
studying how v-src influences gene-expression. A similar strategy has been partially suc­
cessful in delineating some of the actions of another oncogene, ras (DeFeo-Jones et al.,
1983; Powers et al., 1984; Toda et al., 1985). My efforts in this direction are detailed in
Chapter 4.
Since transcription mechanisms between yeast and animal cells appear to be very
similar, the first part of this project was confined to checking if the RSV LTR directs
transcription in yeast (the answer is "yes") and if similar transcriptional elements were
used in yeast as in mammalian cells (again a "yes"). The second part involved the intro­
duction of v-src into the yeast. It had already been shown that v-src can be expressed
in yeast, where it retains its strong tyrosine kinase activity and its subcellular localiza­
tion (Kornbluth et al., 1987; Brugge et al., 1987). However, the over-expression of v-src
is toxic to the yeast, and we had to devise strategies for expressing minimal quantities of
v-src and examining its effects on the RSV LTR. The final answer is not in yet, but v­
sr c may be stimulating expression from the RSV LTR in yeast and it may be possible to




In the epilogue, I allude to one of the clones of yeast expressing v-sr c which exhibits
a phenotype that is consistent with "schmoo" formation. Schmoos are normally formed
by yeast when they are exposed to mating factor of the opposite mating type. The
response by yeast to mating factor is intensively studied as a model of signal transduc­
tion, and has been shown to utilize an adrenergic receptor-like receptor and alpha, beta
and gamma subunits of G proteins (Nakayama et aI., 1985; Hagen et aI., 1986; Nakafuku
et al., 1987; Dietzel and Kurjan, 1987; Whiteway et aI., 1989). It may be possible that
this clone of yeast has a mutation at another locus which enables v-src to turn on the
mating factor signal transduction pathway in the absence of mating factor. Should this
prove to be true, then this clone of yeast can give us another route to isolating genes on




In this chapter we address the induction of the RSV LTR in untransformed 3Y1 by
serum. We show that serum induces transcription from the RSV LTR, that mutations
in two CCAAT boxes in the LTR abolish the serum-responsiveness and that the
CCAAT boxes bind to a serum inducible nuclear factor which fails to bind when the
CCAAT boxes are mutated. The CCAAT box binding factor appears to belong to the
CTFJCP class of factors.
Transcription from the RSV LTR has been studied extensively. The presence of an
enhancer in the 5' part of the LTR has been defined by linking it to a heterologous pro­
moter and by mutagenesis both in the context of the natural sequences and when the
enhancer drives expression from a heterologous promoter (Gorman et al., 1982b; Luciw
et al., 1983; Laimins et al., 1984; Cullen et al., 1985; Weber and Schaffner, 1985; Norton
and Coffin, 1987; Gowda et al., 1988). The major part of the enhancer maps to the
absolute 5' end of the LTR (Fig. 2), though some enhancer activity has also been noted
immediately 3' to the Sph I site. Mutagenesis studies have also defined essential pro­
moter elements in the LTR. The minimal sequence required for transcription from the
LTR, in vivo and in vitro, appears to be confined to the TATA box which is at position
-25 relative to the transcription "start" site (Yamamoto et al., 1980; Mitsialis et al.,
1983; Gilmartin and Parsons, 1983).
Nuclear proteins that bind to the LTR have also been studied extensively (Sealey
and Chalkley, 1987; Karnitz et al., 1987; Goodwin, 1988; Ryden and Beemon, 1989). It
appears that there are two major DNA binding proteins that bind to the RSV LTR.
One of these binds over the classical enhancer, and the second binds immediately down­
stream from the Sph I site. Arrigo et al. (1987), and Carlberg et al. (1988) have also
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demonstrated the existence of an internal enhancer in the gag region of the intact avian
retrovirus which may influence expression from the 5' LTR. Further, they have shown
that the CCAAT binding protein C/EBP from rat liver extracts (Landschulz et al., 1988)
footprints on both the gag enhancer 'and the enhancer in the 5' end of the LTR (Carl­
berg et al., 1988; Ryden and Beemon, 1989). Hatamochi et al. (1988) and Maity et al.
(1988) reported the presence of a CCAAT binding protein that, unlike C /EBP, is com­
posed of two subunits. The factor, CBF, stimulates transcription from the RSV LTR in
vitro and footprints over regions -146 to -121 and -82 to -56 of the LTR.
Not much is known about environmental signals that influence transcription from
the RSV LTR. Temin (1967) reported that while RSV can infect chicken embryo fibrob­
lasts (CEF) in the absence of serum, virus production is not resumed until after the
addition of serum. Leong et al. (1972) showed that once the pH of the medium was
adjusted by the addition of NaHC03, virus production from a RSV infected culture of
CEF is not dependent on the presence of serum. Humphries and Temin (1972, 1974)
demonstrated that once virus production has started in RSV infected CEF, serum
deprivation had no effect on the synthesis of viral RNA and proteins. In contrast, in
uninfected CEF, the production of endogenous viral RNA and protein was stimulated
upon addition of serum to a serum-deprived culture (Chen et al., 1974). Endogenous
retroviruses have LTRs that resemble the RSV LTR in general structure, but are shorter
in the U3 region and lack the enhancer (Hughes, 1982).
All the results given above could be reconciled if it is hypothesised that in the unin­
fected (untransformed) cell, expression of a gene linked to the RSV LTR is dependent on
serum, while transformation of a cell by V-STC makes the LTR serum-independent. In




Cella and culture conditions.
3Yl is an immortalised, untransforrned line of rat fibroblasts. They were grown in
Dulbecco's modified Eagle medium (DEM) containing 5% calf serum (5% CS DEM).
o ligodeoxynucleotidea.
The oligos used were as follows:





ANDU 120: 5' AGTAAGGTTTTACGATCG3 ' .
ANDU140: 5 'TGCCGATTT'ITGGAAGTA3' .
Hsp70 5'TTCTTTTCTTTCTTCCCTTCTGAGCCAATCACCGAGCGCCCTAC3'
3 ' AAGGGAAGACTCGGTTAGTGGCTCGCGGGATG5 '











RSVCAT (Gorman et al., 1982b) is a plasmid that has the U3, R, and U5 regions of
the Rous sarcoma virus Long terminal repeat along with the 3' intergenic region between
the v-src and the LTR linked upstream of the bacterial chloramphenicol acetyl
transferase (CAT) gene (Fig. 2). The resulting plasmid has been shown to direct the
expression of the CAT gene using transcripts initiating at the correct initiation site in
the RSV LTR. RSVNEO is a construct similar to RSVCAT that has the same RSV
fragment driving the bacterial neomycin phosphotransferase gene. .6.SMCAT was made
by cutting RSVCAT at unique Sph I and Mst II sites, blunting with Klenow, ligating
with T4 DNA polymerase selecting against parental plasmid by cutting with Sph I and
Mst II and transforming E. Coli. .6.RSCAT was made by cutting RSVCAT with Eco RI,
blunting, ligating with Sph I linkers, digesting with Sph I and Hind III, isolating the 80
bp Sph I (formerly Eco RI at -51 relative to the RSV transcription start site) to Hind III
fragment and cloning it into the large Sph I to Hind III fragment obtained from
RSVCAT. 114BgCAT was made by partial digestion of RSVCAT by Pvu I, isolating the
full length linear plasmid from an agarose gel, blunting it and ligating Bql II linkers fol­
lowed by selection of the correct construct by transforming E. coli to ampicillin resis­
tance. 51BgCAT was made similarly by partial digestion of RSVCAT with Eco RI and
ligating Bgl II linkers. 114BgCAT was cut at unique sites by Bgl II and Mst II ,blunted ,
ligated, cut once again with the same restriction enzymes and then transformed into E.
Coli to produce .6.PMCAT. .6.PSCAT was made similarly by using Sph I instead of Mst
II.
p18LTR was made by cloning the 440 bp Pst I - Ec o RI fragment from a molecular
clone of RSV 29 (Dutta et al., 1985) into the blunted Xba I site in the polylinker of
PE�mL18 (Dente et al., 1983) and screening for inserts in both orientations. pC
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contains the 90 bp Eco RI - Sph I fragment of the LTR cloned between the blunted Xba
I and the Sph I sites in the polylinker of PEMBL18 and was derived from one of the
orientations of p18LTR by SphI digestion and ligation. pB contains the Sph I - Mst II
fragment of the RSV LTR cloned between the blunted Bam HI and the Sph I sites of
PEMBL18 and was also obtained from p18LTR by digestion with the appropriate
enzymes. p18SV2 contains the SV40 enhancer (SV40 nucleotide 108-299) in a Taq I -
Kpn I fragment from pXS16 (Fromm and Berg, 1982) cloned between the Ace I and Kpn
I sites of PEMBL18.
The point mutations were made using a MUTAGENE kit (Bio-Rad). E. coli CJ236
(dut, ung) was transformed with pC and uracil containing single stranded DNA rescued
by superinfecting the transformants with helper phage IR1gfip. pC80, 120 and 140 were
made by using mutagenic oligos ANDU80, 120 and 140, respectively, on this template to
make the second strand. The reaction products were used to transform E. coli MV1190
(dut+, ung+j destroy's the uracil containing parental strand) to ampicillin resistance.
Candidate colonies were picked by differential hybridization of colony lifts to the
mutagenic oligos and the mutations were confirmed by sequencing miniprep DNAs using
the universal primers. pC140 was used, instead of pC, as the starting plasmid and the
above process repeated with ANDU80 and 120 to produce pC814 and pC1214 respec­
tively. pC134 was the only mutant that we could obtain using the degenerate oligo
ANDU4 in the above procedure and screening for mutants by directly sequencing several
miniprep DNAs.
pm80CAT, pm140CAT and pm814CAT were created by isolating the 100 bp Bam
HI - Sph I fragment from pC80, pC140 and pC814 respectively and ligating it into the 5
kbp Bgl II -Sph I fragment from 51BgCAT. �SM80CAT, �SM140CAT and
�SM814CAT were derived from pm80CAT, pm140CAT and pm814CAT respectively,
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by cutting the parental plasmids with Sph I and Mst II, blunting with Klenow and ligat­
ing.
pAD5 was made by cloning the ANDU2/ANDU3 oligomer into the Bam HI site of
pUC18. pAD5pm1 was made by hybridizing ANDU2 with ANDU5 and cloning the
mismatched oligo into the Bam HI site of pUC18, followed by sequencing miniprep
plasmid DNAs from a few colonies with the universal primer to screen for the mutant.
Transfections.
For the transient transfection assays, the indicated amounts of plasmids were dis­
solved' in 250 J.lI of 25 mM HEPES (pH 7.15) and 250 mM CaCI2. This was vortexed
continuously while 250 J.lI of a solution containing 280 mM NaCI, 1.5 mM Na2HPO4 and
25 mM HEPES [pH 7.15) was added drop-wise. The precipitate was allowed to form for
.
20' at room temperature and was then added to a 60 mm tissue culture dish containing
a sub confluent layer of 3Yl fibroblasts and 5 ml of fresh 5% CS DEM. Six hrs. later the
medium was removed and replaced with 0% DEM (DEM with no serum) after washing
the cells with Tris-buffered-saline (25mM Tris HCI pH 7.4, 137 mM NaCL, 20 mM KCI,
1.5 mM Na2HPO4 and 0.1% w[v glucose). Forty-eight hrs. after serum-starvation, the
medium was supplemented with calf serum to 10% where indicated.
For making stable cell lines, 5 j..lg RSVNEO was transfected into 3Yl cells in the
same way as above. After washing the cells, they were fed with 5% DEM. 48 hrs. later,
the cells were split 1:3 and put under selective pressure (400 J.lg/ml G418). G418 resis­
tant colonies appeared in 2 wks. and these were pooled for subsequent assays.
CAT Assays.
These were done essentially according to Gorman et al. (1982a). The cells were
washed thrice with 10 ml Tris- buffered-saline, harvested by scraping with a rubber
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policeman, and lysed in 100 III of 0.25 M Tris HCI (pH 7.8) by 3 cycles of freeze thawing.
The protein content in the lysate was assayed by the Bio-rad dye binding assay. 50 - 70
Ilg of protein was used for each assay which was carried out in 100 III of 0.25M Tris
HCI (pH 7.8), 33 III of 1.0 M Tris HCI (pH 7.8), 20 III of Acetyl CoA (3.5 mgj'rnl] and 2.5
III of
14 C Chloramphenicol (0.25 IlCi; 60.0 mCi/mmol). The reactions were carried out
for 40 mins. at 370 C, stopped by extracting in 1 ml of ice cold Ethyl Acetate which
was then dried down and dissolved in 30 III of Ethyl Acetate. The reaction products
were separated by Thin layer chromatography on silica gel using a mixture of chloroform
: methanol as 95 : 5. The positions of the chloramphenicol and acetylated chloramphen­
icol were determined by autoradiography, the spots were excised and counted by liquid
scintillation and the percentage chloramphenicol acetylated was calculated. Preliminary
experiments had shown that the acetylation of chloramphenicol proceeds in a linear
fashion under the conditions indicated.
S 1 Nuclease Assays.
Total cellular RNA was prepared from the transfected cells by the method of Cox
(1968). 20 J-lg of total RNA was mixed with gel purified, end labeled probe (100 000
cpm) in 20 JLl of a solution containing 80 % formamide, 400 mM NaCI, 10 mM PIPES
(pH 6.4) and 1 mM EDTA. The mixture was heated to 650 C for 10 mins. and the
probe and RNA allowed to anneal at 450 C for 16 hrs .. This was then diluted to 200 J-li
containing 250 mM NaCI, 30 rnM NaAcetate and 1 mM ZnSO4 and digested with 100
units of S 1 enzyme at 370 C for 1 hr.. The reaction was stopped using 600 J-li of cold
ethanol to precipitate the nucleic acids which were then resolved on a 4% acrylamide
(30% acrylamide : 0.8% bis-acrylamide) - urea (50%) gel with Ix TBE buffer (89 mM
Tris borate, 89 rnM boric acid, 2 mM EDTA).
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Slot blots, Northerns and Nuclear run-on Assays.
These were essentially performed as in Sugano et al. (1987) and Stoeckle et al.
(1988). For slot blots we used 3 ug. (1 J.lg where indicated) of total RNA and probed
with nick translated pRSVNEO. Northerns were performed with 5 J.lg of total RNA run
on a formaldehyde containing agarose gel and transferred to a nylon membrane (Zeta­
bind). For the run-on assay we blotted 1 J.lg/slot of the Hind III to Nco I fragment of
RSVNEO containing the neomycin phosphotransferase coding portion, and 5 J.lg/slot
each of pFos (the 1.0 kb Pst I fragment of murine v-fos cloned into pUC 18, Curran et
al., 1982), pTub (1.7 kb chicken beta tubulin cDNA cloned into the Pst I site of pBR322,
Cleveland et al., 1980), p28S (4.8 kb Sal I - Ec o RI fragment of mouse 28S rRNA
genomic DNA clone in pBR322, Tiemeier et al. 1977), pUC18 and ¢>X174 DNA. The
assay itself was performed as described in Friedman et al.(1986).
Nuclear extracts.
These were prepared according to Dignam et al. (1983) as modified by Prywes et al.
(1986). Briefly about 107 cells were washed thrice with Tria-buffered-saline on ice and
harvested by scraping with a rubber policeman. The cells were swollen in Buffer A (10
mM Tris HCI pH 8.0, 1.5 mM MgCI2, 10 mM KCI, 0.5 mM DTT, ImM PMSF and 1 %
Trasylol), broken by 25 strokes of a Dounce homogenizer with a type B pestle, the nuclei
were collected and then extracted in 100 - 150 J.lI of Buffer C (300 mM KCI, 20 mM Tris
HCI pH 8.0, 25 % v[v glycerol, 1.5 mM MgCI2, 0.2 mM EDTA, 1 mM PMSF and 1 %
Trasylol) for 30 mins.. After the extracts were made, they were dialysed against 500 -
1000 volumes of BClOO (100 mM KCl, 20 % v/v glycerol, 0.2 m.M EDTA, 0.5 mM DTT,
20 mM Tris Hel pH 8.0, 1 mM PMSF, 1 % Trasylol) across a Millipore VS filter (0.025
J.lm diameter pore size).
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Gel mobility shift assays.
Usually 10 J-Lg of nuclear extract was preincubated in a 24 J-LI volume of 10' mM Tris
HCI pH 7.6, 1 mM DTT, 5 % v/v glycerol, 1 mM MgCI2, 4 J-Lg poly dI-dC/dI-dC, 1 J-Lg
of plasmid DNA and 60 mM of KCI (or KCI + NaCI) for 10 mins. at 250 C. 1 ng probe
(100,000-200,000 cpm) in 1 JLI volume, labeled by T4 polynucleotide kinase or by end
filling with Klenow, was added and incubation continued for 20 mins. The whole mix­
ture was loaded on a 4 % acrylamide gel (30 % acrylamide : 0.8 % bis-acrylamide) with
0.25X TBE and electrophoresed at 180 V for 90 mins. at 40 C.
Exonuclease ill assay.
These were done according to Wu (1985). The DNA binding conditions were the
same as described above, except that 20 J-Lg of nuclear protein was used. At the end of
the binding reaction, Exonuclease III was added to the required concentrations and incu­
bated for 15 mins. at 300 C. The reaction was stopped by adding an equal volume of a
solution containing 40 mM Na2EDTA and 2 % SDS followed by phenol extraction and
chloroform extraction. The products were precipitated with ethanol, denatured in 25 J-LI
of sequencing gel buffer and resolved by electrophoresis on a 16 % acrylamide (acryl : bis





We discovered the serum-responsiveness of the RSV LTR in the course of attempts
to compete for transcription factors binding to the RSV LTR in vivo. Transient
transfection assays were done on untransformed 3Yl fibroblasts using a plasmid referred
to as 5'+CAT. This plasmid contained a region from the 3' end of RSV spanning the
Pst I site (-491 relative to transcription start site in the LTR) to Eco RI site (at -51),
ligated in the correct orientation upstream from the minimal early promoter of SV40
driving the CAT gene. The presence of the fragment from the RSV (containing most of
the U3 region except for the 3' end containing the TATA box) stimulated expression
from the SV40 minimal promoter (containing only the A/T box and the Sp 1 binding
sites) by 5 fold. When the saine Pst I to Eco RI fragment of the LTR ins�rted into
pEMBL 18 (p18LTR) was used in competition in vivo against 5'+CAT, a 19:1 molar
ratio of the competitor to the CAT plasmid resulted in a decrease in CAT activity to
20% of the activity from the uncompeted 5'+CAT. Our conclusion from this was that
the U3 region contained in 5'+CAT acted as a transcriptional enhancer, and that it did
so by binding sequence-specific DNA-binding proteins, because the enhancing activity
could be competed away by the enhancer in p18LTR.
The observation that the competition was best seen when the transfections were
done with a confluent layer of 3Y1, made us examine if the growth state of the cells was
important for the competition. To this end we performed the competition experiments
with a sparse culture of 3Yl' which were either allowed to grow normally after transfec­
tion or were made stationary by depriving them of serum. To our surprise, the depriva­
tion of serum not only allowed more effective competition by p 18LTR, but also substan-
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FIGURE 1. Serum induces transcription from the RSV LTR in the absence of new
protein synthesis.
(A) (Upper panel) S1 Nuclease analysis of total RNA from 3Y1 transfected with
RSVNEO and RSVCAT. "-": cells in 0% DEM for 48 hrs .. "+": cells in 0% DEM for
48 hrs. followed by addition of calf serum to 10% (vIv); incubation was continued for
another 6 hrs .. The probes were RSVNEO and RSVCAT, cut and labelled at an unique
Nco I site in the NEO and CAT gene respectively. The sizes of the fragments protected
by correctly initiated transcripts are 950 bases for RSVNEO and 577 bases for RSVCAT.
(B) (Lower panel) Induction of NEO RNA in 3Y1 carrying RSVNEO stably
integrated in the genome. Serum was added to 10% to cultures starved of serum for 48
hrs., total RNA was harvested at the times indicated and 3 j.lg of RNA was used per slot
in the slot blots (S). In parallel plates, cycloheximide was added to 50 J.Lg/ml before
adding serum and in this case 1 j.lg of RNA was used per slot (CH+S). The slot blots
were quantitated by densitometry, the NEO RNA levels at the various time points were
















tially decreased the CAT activity even in the uncompeted cultures. This suggested, (a)
that the presence of serum increased the level of some limiting factor that interacts with
the RSV LTR upstream of the Eco RI site at -51 and is responsible for the "enhancer"
activity of the same, and (b) that serum was required for the "enhancer" activity of the
RSV LTR. We decided to examine both these issues directly.
Serum stimulates the level of transcripts initiating at the RSV LTR without
requiring new protein synthesis.
RSVCAT (Gorman et al., 1982b) and RSVNEO contain identical parts of RSV,
namely the 3' intergenic region between v-src and the 3' LTR, the whole of U3, the R
region of the LTR and part of U5 (Fig. 2), ligated upstream from the bacterial chloram­
phenicol acetyl transferase (CAT) gene or the neomycin phosphotransferase (NEO) gene
(respectively) such that transcripts initiating in the LTR continue into the CAT or NEO
gene and are processed at the 3' ends of these genes at an SV40 polyadenylation site.
To test if the transcripts initiating in the RSV LTR were induced by serum, a mix­
ture of 5 jlg RSVCAT and 5 jlg RSVNEO was precipitated onto immortalized rat fibrob­
lasts 3Y1; after 6 hrs., the plates were washed twice with Tris-buffered-saline, and the
medium replaced with DEM containing no calf serum (0% DEM). After 48 hrs., calf
serum was added to half the plates to 10% (v Iv), and 6 hrs. later total RNA was iso­
lated from the serum depleted cultures (Fig. lA lane -) and from the serum stimulated
cultures (lane +). As shown in Fig. lA the steady state levels of accurately initiated
transcripts as measured by Sl nuclease analysis were stimulated by serum about 5x for
both RSVCAT and RSVNEO. This implies that the serum responsive signals are likely
to be in the RSV LTR parts ?f the two plasmids.
A line of 3Yl containing stably integrated copies of RSYNEO was created by
transfecting 3Yl with linearized RSVNEO DNA and selecting for G418 resistant
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FIGURE 1.
(C) Nuclear run on transcripts were prepared from the cell line used in (B) 48 hrs.
after serum deprivation (0) and 1 hr. after addition of serum to 10%. The probes used








colonies. About 20 such colonies were pooled to create the cell line. When this cell line
was starved of serum for 48 hrs., and then serum was added to 10% (v Iv) to some of the
cultures, the time course of induction of NEO transcripts (Fig. IB) shows that maximum
induction is reached in 1 hr., remained high for 5 hrs. and then declined slowly. SI
nuclease analysis (data not shown) revealed that the NEO transcripts were initiated at
the correct site in the LTR.
In a parallel experiment, 3Yl stably transformed with RSVNEO, was starved of
serum, pretreated with cycloheximide at 50 J.lg/ml, and then treated with serum. As
shown in Fig. IB, cycloheximide treatment alone increased the steady state NEO RNA
level twofold, and serum still stimulated the RNA level about fivefold above baseline
despite the presence of an inhibitor of protein synthesis.
Nuclear run-on assay using this cell line (Fig. lC) shows that the effect of serum on
the steady state message from RSVNEO could be accounted for mostly by the stimula­
tion of transcription from the RSV LTR. The presence of transcripts hybridizing to
pUC18 indicates that there is some run through transcription from the NEO transcrip­
tion unit and perhaps upstream cellular promoters into the adjoining pBR322 sequences.
However, the NEO transcription signal is detected by hybridization to a NEO specific
DNA fragment which is devoid of any DNA that could hybridize to this pBR322 back­
ground. Furthermore, no background signal is detected using ¢>X174 DNA as a negative
control (data not shown).
The serum responsiveness of the RSV LTR maps primarily to two CCAAT
box sequences.
The structure of the RSV LTR used in RSVCAT is indicated in Fig. 2. A series of
deletions were made using convenient restriction enzyme sites as shown in Fig. 3. 10 J.lg
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FIGURE 2. The RSV LTR and point mutations made in it.
The structure of the RSV LTR at the 3' end of the provirus is shown. The Pvu II
to Bst NI (converted into a Hind III site) is contained in RSVNEO and RSVCAT. The
start site of transcription used by the virus is indicated as + 1 and all other restriction
sites shown relative to it. The positions of the TATA box and the classical enhancer are
indicated. RI: Eco RI.
The lower half of the figure shows the sequence of part of the LTR which is cloned
into pEMBL 18 to give pC. The lines below indicate the mutations made in this frag­
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of RSVCAT and each of the deletion constructs shown were transfected into parallel cul-
tures of 3Yl. After 6 hours of exposure to the DNA precipitate, each culture was
washed twice with Tris-buffered-saline and placed in 0% DEM for 48 hrs.. Calf serum
was added to 10% (vIv) and 12 hrs. later the cells harvested, lysed, and equal quantities
,
of protein were used to measure the amount of CAT activity derived from RSVCAT and
each of the deletion derivatives. For each experiment, each plasmid was transfected into
at least 2 different plates of cells and the CAT activity determined separately. The CAT
activity obtained from RSVCAT was considered to represent the 100% level of activity
obtained from the intact LTR upon serum stimulation. The CAT activities obtained
from each of the other plasmids were expressed as a percentage of the activity obtained
from RSVCAT. The results are presented as a mean +1- standard deviation with the
number of independent transfections shown in parentheses.
It can be seen from the results in Fig. 3 that .6.SM deletion which deletes the con-
ventional RSV enhancer did not significantly diminish the serum induced CAT activity
relative to RSVCAT. However, extending the deletion to the Pvu I site (.6.PMCAT)
caused the CAT activity to drop to 40% the level relative to RSVCAT. Extending the
deletion still further to the Eco RI site (.6.RMCAT) caused the activity to drop to 2%
relative to RSVCAT. These results indicate that the serum responsiveness of the RSV
LTR resides mostly in two segments .: Eco RI - Pvu I and Pvu I - Sph I. This is
confirmed by the result with .6.RSCAT where removal of both the serum responsive ele-
ments decreases the CAT activity to 6.5% the level of RSVCAT. It is of interest to note
that the deletion in .6.PSCAT is not as effective in decreasing CAT activity as the dele-
tion in .6.PMCAT, suggesting that the enhancer in the Sph I - Mst II fragment (SM frag-
ment) can partially compensate for the absence of the Pvu I - Sph I element (PS ele-
ment).
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FIGURE 3. Serum responsiveness of the RSV LTR maps primarily to two CCAAT
sequences.
CAT activities obtained by transient transfection of RSVCAT and its derivatives
into 3Yl (as described in the text) is shown along with the names of the plasmids and
schematic representations of the mutations in the plasmids. RSV for RSVCAT, SM for
ASMCAT, pm80 for pm80CAT, SM80 for ASM80CAT etc .. Restriction enzyme sites
indicated for RSVCAT are R: Eco RI, P: Pvu I, S: Sph I, M: Mst II (Fig. 2). In the
schematics, gaps indicate deletions made using the restriction enzyme sites shown, and
dots indicate point mutations (Fig. 2). The CAT activities are normalized to RSVCAT
(100%); the number following the + is the standard error of the number of independent
observations shown in parenthesis.
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% CAT activity relative
to RSVCAT u�on 12 hrs.
of serum st1mulation.
1 __ 2.0 ± O.B (4) RM
37.0 � 1.4 (2) PM
______ 1' 9B.4 � 5B.0 (10) SM
M s P R
_________ 1 1_1__ 1 99.3 ± 17.7 (13) RSV
6.5 � 2.1 (4) RS
53.3 ± 39.7 (3) PS
M f_I__�1 99.3 ± 17.7 (13) RSV
•
15.2 ± 4.2 (6) prnBO
•
97.0 ± 35.B (4 ) pm120
71.8 ± 19.3 (6 ) pm140
•
50.7 � 22.1 (7) dpmS14
7 T 98.4 1. 58.0 (10) SM
•
2.5 ± 2.1 (2) SM80
I. 10.0 ±. 8.2 (7 ) SMl40




In an attempt to define the transcriptional elements most necessary for wild type
activity upon the addition of serum, we examined the Eco RI - Sph I (RS fragment)
sequence (Fig. 2). The CAT assays presented above indicated that the RS fragment con­
tained the elements that were most important for serum stimulated transcription. RNA
data to be presented at the end of this section will confirm that these elements are
important for both the basal level of activity in the absence of serum, and the induction
of activity seen upon the addition of serum. Two CCAAT boxes were noted in the
antisense strand of the RS region as shown in Fig. 2. Using oligonucleotide directed
mutagenesis, we made the mutations shown in Fig. 2 and introduced the pm80, pm120,
pm140 and dpm814 mutations into the RSV LTR of RSVCAT. These mutants were
analyzed in the same way as the deletion plasmids and the results are presented in Fig.
3. pm80CAT produced 15% of the CAT expressed by RSVCAT, indicating that the
promoter proximal CCAAT box ("80") is very important for serum responsiveness.
pm120CAT showed no decrease in CAT activity while pm140CAT showed a minor
decrease. However, in light of the difference between �PMCAT and �PSCAT discussed
above, we made additional constructs where the mutations of pm80CAT and
pm140CAT were introduced into an LTR that already has a deletion of the SM frag­
ment. The results with �SM80CAT and �SM140CAT map the two transcriptional ele­
ments in the RS fragment to the two CCAAT boxes.
The enhancer in the SM fragment appears to have some role in the serum stimu­
lated transcription in view of the differences between �PSCAT and �PMCAT and also
pm140CAT and �SM140CAT. Further, the introduction of the 140 mutation into an
LTR that already has a mutation in the proximal CCAAT box (dpm814CAT) causes an
increase in serum stimulated CAT activity relative to pm80CAT. This is not seen when












basal level of mutantlinduction ratio of· mutantrelative to wild type relative to wild type
RSVCAT 2.5 6.3 1 1.3
RSVNEo 12.0 23.2
�SCAT 1.0 5.1 1.3 1.1
RSVNEO 3.6 17 .2
3.
l::$MCAT 7.5 57.2 n.d. 0.71
RSVNEO 8.6 92.2
�CAT 1.1 2.2 0.52 0.41
RSVNEO 10.0 49.1
The amount of CAT RNA produced frcrn each XCAT plasmid in the absence of serum
(basal level) and 2 hrs after addition of serum (induced level) was measured
by transient transfection, followed by 51 nuclease analysis of the RNA.
RSVNEO was used as an internal control for transfection and for serum induc­
tion. For l2$MCAT, the basal level could not be detected by transient transf­
ection. Therefore, we created a stable cell line containing l2$MCAT and
RSVNEO by co-transfecting the two plasmids, selecting for and pooling several
G4l8 resistant colonies. The levels of CAT and NEO transcripts before and
after addition of serum were measured with this cell line by Northern blot
analysis with CAT and NEO sp€cific probes. In all cases, the relevant signals
were.quantitated by densitometry and the results presented in columns 2 and 3.
1. XCAT';- RSVNEO in XCAT transfection / RSVCAT � RSVNEO in RSVCAT
transfection
+ +
2. XCAT -;- XCAT / RSVNEO:- RSVNEO in same trans fection as XCAT.
3 . not detenninable I because the induction ratio was measured using
a cell line carrying ,&MCAT and RSVNEO stably integrated in to the genome.
Hence unlike the other XCATs I the basal level of the L$MCAT plasmid could not




the presence of the enhancer has a stimulatory effect on the serum responsiveness of the
intact LTR and this is interfered with by the distal CCAAT sequence ("140" CCAAT)
in the pm80CAT construct.
To ensure that the effects seen with the mutations were a reflection of change in
the induction ratio and not merely due to changes in the basal level of expression, the
experiment shown in Fig. lA was repeated with some of the mutant CAT plasmids. 10
pg/plate of RSVCAT (or some of the mutant CAT plasmids) and 5 Jlg/plate of
RSVNEO (as an internal control for transfection) were co-transfected into 3Yl, the cells
were serum starved for 48 hrs., the plates were treated with serum (10% v /v) for 2 hrs.
before total cellular RNA was purified from the cells and subjected to SI analysis for
accurately initiated CAT and NEO transcripts. The bands corresponding to the CAT
and NEO transcripts were quantitated by densitometry, and the results presented in
Table 1. As can be seen, a decrease in induction ratio relative to wild type was seen
with �RSCAT and to a lesser degree with �SMCAT. This supports our conclusion that
the serum responsiveness resides mostly in the RS fragment. The SM fragment may
playa secondary role. It should be noted that the deletion of the RS fragment is also
accompanied by a decrease in the basal level of activity (the activity in the absence of
serum). However, if this decrease in basal level of activity was due to elements that
were not responsible for the serum induction, one would not expect to see an accom­
panying decrease in the induction ratio: the induced level of the mutant would be
decreased relative to wild type induced level by the same factor as the mutant basal
level would be decreased relative to wild type basal level. The fact that this is not the
case suggests that the elements in the RS fragment are responsible for both the basal
level of activity and for the induction by serum. The argument is bolstered by the
observation that deletion of the SM fragment has a much greater effect on the basal
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FIGURE 4. Induction by serum of a nuclear factor binding to the RS fragment.
(A) (Upper picture) Gel mobility shift analysis. Left panel: probe is the Eco RI -
Sph I fragment (RS) of the RSV LTR. Right panel: probe is the Sph I - Mst II fragment
(SM) of the LTR. The plasmids in the reactions were:- lanes 1, 3, 5, 7: pEMBL 18; lanes
2, 4: pC (pEMBL 18 with the RS fragment cloned in it]; lanes 6, 8: pB (pEMBL 18 with
the SM fragment cloned in it). The nuclear extracts used were from serum starved 3Y1
(1, 2, 5, 6) or from 3Y1 treated with 10% serum for 2 hrs. after serum starvation (3, 4, 7,
8). Specific DNA-protein complexes are marked for RS (arrowhead) and SM (arrow).
(B) (Lower picture) Exonuclease III footprinting. The Eco RI - Hind III fragment
of pC containing the RS fragment and the Hind III site from the polylinker of pEMBL
18 was labelled at the Hind III site by T4 polynucleotide kinase. Lanes 1-4: nuclear
extract from serum-stimulated 3Yl. Lanes 5-8: no extract. Exonuclease III concentra-
tions were 0 u/rnl (1, 5), 135 u/rnl (2, 6), 450 u/ml (3, 7), and 1500 u/rnl (4, 8). The
labelled, upper strand of the RS fragment is represented next to the gel with the posi­
tions of some restriction enzyme sites. R: Eco RI, P: Pvu I, Sau: Sau IlIA, Rsa: Rsa I, S:
Sph I. The lanes marked with letters representing restriction enzymes are size markers
created by cutting the labelled DNA with the corresponding enzymes.








level (it could not be detected by transient transfection assays) without an equivalent
effect on the induction ratio. Thus a decrease in the basal level would not automatically
cause an equivalent decrease in the induction ratio, unless the element responsible for
the basal level of activity was also responsible for the serum-responsiveness. We are
currently extending this analysis to the plasmids carrying the point-mutations.
Till the data from the point mutations is available, it is not possible to definitively
say that the same elements in the RS fragment that are responsible for the basal level of
transcription are also responsible for the induction. Theoretically, it could be envisaged
that the RS region contains elements responsible for basal activity, like the CCAAT ele­
ments, and other elements that are responsible for the induction. However, the data
presented below shows that the only nuclear factors that bind to the RS region do so
through the CCAAT elements, making it highly likely that the CCAAT elements are the
only transcriptional elements in the RS region, and they are responsible for both the
basal level of activity and the induction by serum.
Serum induces the appearance of a nuclear protein that binds to the RS frag­
ment.
Nuclear extracts were prepared from 3Yl starved of serum for 48 hrs., and from
parallel cultures that, after serum-deprivation, were exposed to 10% calf serum (vIv) for
2 hrs. before making the extracts. Gel retardation DNA binding assay (Fig. 4A) revealed
that a nuclear protein bound specifically to the RS fragment (the band marked with an
arrowhead disappears when cold RS fragment is put in competition in lanes 2 and 4).
Further, the abundance of the protein is increased upon exposure of the cells to serum
(lane 3 compared to lane 1). In contrast, the nuclear protein(s) binding to the enhancer




(C) Gel mobility shift assay using labelled RS fragment (left panel) and PS frag­
ment (right panel). PS was made by annealing oligos ANDU 2 and 3 and purifying the
double-stranded oligo on a gel. The competing plasmids and oligos present in a reaction
are indicated above the lanes. p 18: pEMBL 18. pC: pEMBL 18 with one copy of the RS

















The experiments using deletion constructs above showed that there were two serum
responsive elements in the RS fragment separated by the Pvu I site. When an exonu­
clease III mapping was done to gain an idea of where the nuclear proteins may be bind­
ing to the RS fragment (Fig. 4B), one could distinguish two major exo III pause sites on
the upper strand of the RS fragment. As can be seen on comparing lanes 4 and 8 of Fig.
4B, one pause site appears to be between the Eco RI and Pvu I sites and a second pause
site appears to map just to the left of the Pvu I site.
Two oligonucleotides (ANDU 2 and 3) were synthesised such that they could be
annealed to form a double stranded DNA fragment that was homologous to the PS frag­
ment. This synthetic PS fragment could compete for the factor binding to the RS frag­
ment in a gel retardation assay (Fig. 4C), suggesting that the two serum-responsive ele­
ments in the RS fragment (only one of which is on the PS fragment) may be binding the
same nuclear factor. The PS fragment could itself be shifted up in a gel retardation
assay and this could be competed for by the entire RS fragment (Fig. 4C right panel) or
by cold PS fragment (data not shown).
The RS fragment binding factor binds to the two CCAAT box sequences.
The point mutants made in the RS fragment that are shown in Fig.2 were each
cloned into the polylinker of pEMBL18 and these plasmids were used to compete for the
RS binding factor in a gel retardation assay (Fig. 5). The appearance of two bands upon
gel retardation with the RS fragment {Fig, 5) or PS fragment (data not shown), as
opposed to the single band seen in Fig. 4, seems to depend on the concentration of the
nuclear protein extract. As can be seen, mutants that retain even one of their CCAAT
boxes (pC-80, pC-140) still compete for the RS binding factor, while mutants that have
lost both their CCAAT boxes (pC-814) fails to compete for the RS binding factor. This
definitely demonstrates that the serum inducible nuclear protein that binds to the RS
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FIGURE 5. The serum induced nuclear protein binds to the CCAAT sequences in the
LTR.
Gel mobility shift assay with the RS fragment and nuclear extract from serum­
stimulated 3Yl. The plasmid present in competition in each reaction is indicated above
each lane, e.g. p18: pEMBL 18, C-80: pC with the pm80 mutation (Fig. 2) etc ..
....
0 "'III:t 0 "'III:t "'III:t E0 .... ....
CO Q.N'





fragment does so through either of the two CCAAT box sequences that have already
been identified as the major mediators of the serum responsiveness of the RSV LTR.
The right hand panel of Fig. 5 confirms that the PS fragment alone can compete
for the RS binding factor (pAD5 has one copy' of the PS oligo cloned into pVC18) and
this is abolished by a mutation in the CCMT box of the PS fragment (pAD5pm1; Fig.
2).
As pointed out in the discussion of Table 1, the RS fragment appears to contain
elements that are responsible for both the basal level of transcription (in the absence of
serum) and for the actual induction seen upon the addition of serum. It is theoretically
possible that the two activities reside in two different elements. However, in view of the
experiments done with nuclear factors, it is clear that the only factors that can be seen
binding the RS fragment are CCAAT binding factors, which makes it very likely that
the CCAAT elements are the only transcriptional elements in the RS fragment and they
are responsible for both the basal level of activity and the induction by serum.
A CCAAT box binding nuclear factor is induced by serum in the presence of
an inhibitor of protein synthesis.
The time course of the induction of nuclear CCAAT box binding factor upon serum
stimulation of serum starved 3Y1 was studied. A gel retardation assay was done with
labeled PS fragment using 3 j.Lg of nuclear protein for each reaction. Two specific bands
were seen which were lost on competition with pAD5 but not pADSpml. Densitometric
scanning of the bands was performed to quantitate the amount of nuclear CCAAT bind­
ing activity seen per j.Lg of protein at the various time points, and the results presented
in Table 2, Experiment 3. The lower band (Band 1) was clearly induced upon addition
of serum, with a time course that is reminiscent of the induction of RSVNEO mRNA
(Fig. IB). The upper band appeared to remain constant. Surprisingly, the amount of
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72 0 0%(0) 3.9 0 1.8 0 7.0
72 0 10%(1) 5.2 1.1 3.1 5.7 16.1
72 0 10%(3) 16.8 4.6 3.2 77.3 53.8
72 0 10%(6) 41.6 3.0 2.8 124.8 116.5
-----------------------------------------------------------------------
Cycloheximide was added to the serwn-starved cultures in experiments land
2 for 15 mins., at the concentrations indicated, before the addition of
serum. The cells were either left in 0% OEM or calf serum was added to
10% (v/v) and incubation continued for the no. of hI'S. shown in
parentheses. Nuclear extracts were prepared in equal vols. of buffer per
plate" and the protein concentrations determined by the dye-binding assay.
Gel mobility shift analysis was done using equal quantities of nuclear
protein per lane and radiolabelled PS probe. Band 1:' the faster moving
specific DNA-protein complex. Band 2: the slower moving DNA-protein comr
plex. Since the probe was in excess, the amount of the probe in a canplex
is proportional to the amount; of CCAAT- binding protein in the extract.
The bands were scanned using a laser scanner and the areas under- the
curves measured by cutting them out and weighing them. The weights in
mgs, divided by the amolillt of nuclear proteins LlSed in the reaction, gives
an estimate of the specific CCMT binding activitY/).lg of nuclear extract
protein. The validity of this measurement was tested by using different
dilutions of the same nuclear extract (data not shown). Because of
differences in the specific activities of the probe and other variations
between the different experiments, the actual numbers'in colwill1s 5-8 can
be compared in the same experiment, but not between experiments. "_".
band not seen. Total CCAAT-binding-activity present per plate was ob­




nuclear protein obtained per plate increases 10 fold upon addition of serum within a
time period that was not sufficient to allow cell division. If this is taken into account,
then the comparisons in the gel shift assays, which used equal quantities of protein per
lane, underestimate the actual induction of the nuclear factors per cell. Thus if one were
to calculate the amounts of proteins that produce Band 1 or Band 2 on a per cell basis
(last two columns of Table 2), then the induction by serum is almost 100 fold and 15
fold, respectively.
In this context, the effect of pretreating the serum starved 3Y1 with cycloheximide
(Table 2, Experiments 1 and 2), before adding serum is interesting. In experiment 1,
serum caused a 12 fold increase in the amount of protein in the nuclear extract. How­
ever the amount of CCAAT binding factor that gave rise to band 1 per j.lg of nuclear
protein was approximately the same in the cells treated with cycloheximide alone as
opposed to the cells treated with cycloheximide and serum. This implies that on a per
cell basis (or as presented in Table 2, a per plate basis), serum stimulated the amount of
nuclear CCAAT factor despite the presence of cycloheximide at concentrations that inhi­
bit nearly 97% protein synthesis in fibroblasts (data not shown). In experiment 2, the
concentration of cycloheximide is enough to inhibit 99% protein synthesis and serum still
causes an increase in nuclear CCAAT binding factor per plate. Closer examination of
the data reveals that while serum can induce nuclear CCAAT factor in the virtual
absence of protein synthesis, the magnitude of the induction is greater when protein syn­
thesis is permitted.
The CCAAT box binding factor that binds to the RSV LTR belongs to the
CTF /CPl,2 class of factors.
Many different CCAAT box binding factors have been characterized (Dorn et al.,
1987; Chodosh et al, 1988a; Landschulz et al, 1988; Santoro et al., 1988; Gil et al., 1988:
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FIGURE 6. The serum induced factor binds to other CCAAT sequences.
(A) (Upper picture) Other CCAAT oligos compete for the CCAAT factor that
binds to the RSV LTR. The PS fragment was labelled and a gel mobility shift assay
performed using nuclear extracts from serum-stimulated 3Yl cells. pAD5 was present in
the reaction for the first lane and pAD5pml in all the other lanes. The oligos (and their
amounts in ng) used in competition are shown above the corresponding lanes For a fun
description of the oligos see MATERIALS & METHODS and Fig. 7.
(B) (Lower picture) The CCAAT factor forms the same sized complex with the PS
oligo and the oligos that can compete for the RSV LTR CCAAT factor. The oligos
shown below the lanes were labelled and used in gel mobility shift assays with the same
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Paonessa et al., 1988; Hatamochi et al., 1988;). Some of the oligos that can bind to them
are presented in Fig. 7. Double stranded synthetic oligomers were used to compete for
the CCAAT factor binding to the PS fragment of the LTR. As shown (Fig. 6A), the oli­
gos that bind the CTF ICP class of oligos, namely, the human Hsp 70 CCAAT oligo, the
human histone 1 CCAAT oligo, and the cHa-ras CCAAT oligo compete for the LTR
CCAAT factor effectively. On the other hand, the nuclear factor 1 (NF 1) binding site
from the adenovirus origin of replication competed poorly and the SV40 enhancer core
oligo which binds C IEBP did not compete at all.
Since some CCMT box factors appear to be composed of a complex of proteins
(Chodosh et al., 1988a; Hatamochi et al., 1988), and since, some transcription factors
form complexes with other proteins (Rauscher III et al., 1988; Shaw et al., 1989), the gel
shift bands 1 and 2 could have been produced by the interaction of the LTR PS frag­
ment with a complex of proteins only one of which is a CCAAT box binding factor. The
data in Fig. 6B indicates that if a complex of proteins binds to the PS CCAAT box, at
least the same sized complex also binds to the CCAAT boxes that compete for the LTR
CCAAT factor (CTFICP). It has been shown that the positions of the bands produced
by the protein-DNA complex in a gel retardation assay is proportional to the sum of the
sizes of the free oligo and the protein(s) binding to it (Bading, 1988). Since all the oligos
used in this experiment were approximately the same size, the co-migration of the
respective protein-DNA complexes implies that protein(s) of the same size are binding to
each of the oligos. As a control, it can be seen that the protein that binds to the SV40
core oligo (C/EBP) produces a complex that is of a different size.
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FIGURE 7. The CCAAT factor binding oligos.
Only the strand containing the CCAAT sequence (boxed in) is shown. The bases
outside the CCAAT box that were the same between the oligos that bind the RSV LTR
CCAAT factor and the consensus sequences developed for known CCAAT factor binding
sites are shaded. "-": same as line below. Lower case letters: bases that were different 3'
to the distal ("140") CCAAT box among the various DNA fragments used in the gel
retardation assays. RSV140: distal CCAAT box in the RSV LTR, RSV80: promoter
proximal CCAAT box in the RSV LTR, Hsp70: CCAAT box from the human heat­
shock-protein 70 promoter, cHa-ras: CCAAT box from the promoter of human cellular
Harvey ras oncogene, H1-TF2: CCAAT box from human histone-1 promoter, Ad2-NF1:
Nuclear factor 1 binding site from adenovirus 2, SV40core: enhancer core sequence of
SV40 72 bp repeats.
The lower half of the figure shows consensus binding sites of three types of CCAAT
binding factors from human HeLa cells (Chodosh et al., 1988a) along with the methyla­
tion interference contact points. Triangles pointing up: contact point on the strand
shown, pointing down: contact point on -the opposite strand. Solid triangles: complete
interference, open triangles: partial interference. The lowest line shows methylation
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The stimulation of transcription from the RSV LTR by serum is part of a
more generalized phenomenon.
Stimulation of transcription from the RSV LTR by serum adds to a list of pro­
moters that are switched on by serum, e.g. c-fos, c-myc, c-jun B, actin (Ryder et al.,
1988; and references therein). This may be a much more generalized phenomenon than
previously suspected. Adding support to this view, is our observation that the transcrip­
tion factor that mediates the serum responsiveness of the RSV LTR is not an unique fac­
tor special for the RSV LTR, but a CCAAT box binding factor that can act on many
cellular promoters. The fact that serum causes a 10 fold increase in total salt­
extractable nuclear proteins per cell' (Table 2), adds credence to the view that the
phenomenon we are observing with the CCAAT box binding factor is typical of many
nuclear transcription factors. This observation is also in line with the reported burst of
3H-uridine incorporation upon addition of serum to a confluent culture 3T3 fibroblasts
(Todaro et al., 1965).
How does serum turn on transcription from the RSV LTR?
As in the instances cited above, the effect of serum on the RSV LTR appears to be
primary, i.e. it can occur without new protein synthesis, suggesting that the transduction
of the signal from serum outside the cell to the nucleus is direct and involves
modification of pre-existing proteins. What could be the mechanisms involved?
Since the induction of nuclear CCAAT box binding factor by serum can occur in
the presence of cycloheximide, and mutations in the CCAAT factor binding sites in the
LTR abolish the binding and decrease both the basal level of transcription in the
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absence of serum, and the induction ratio upon exposure to serum, we propose that the
CCAAT box binding factor mediates the primary signal from serum. One possibility is
that serum induces post-translational modifications directly on the CCAAT box binding
factor and activates its DNA binding activity. This would be analogous to the induction
of the DNA binding activity of the heat shock factor by phosphorylation in response to
heat shock (Sorger et aI., 1987; Zimarino and Wu, 1987; Sorger and Pelham, 1988). It is
of interest that at least one type of post-translational modification has been reported for
the CCAAT box binding factor, i.e. O-glycosylation (Jackson and Tjian, 1988). In view
of the serine phosphorylation of another serum responsive factor, the c-fos SRF (Prywes
et al., 1988), it would be worthwhile to examine whether the CCAAT box binding factor
is also phosphorylated. Any post-translational modification that is found on the
CCAAT factor should be (a) modulated by serum, and (b) influence the amount of
CCAAT binding activity that can be found in the nucleus for it to be implicated in the
signal transduction process.
Another possibility is that serum causes post-translational modifications in another
protein which interacts with the CCAAT factor. It has been proposed that at least two
proteins are required to form a complex for binding to a CCAAT box (Chodosh et al.,
1988a; Hatamochi et al., 1988). This has been found not to be true with cloned CCAAT
box binding factors in vitro (Santoro et aI., 1988), but it could still occur in vivo. It is
therefore possible that serum causes a modification in an accessory protein which is
essential to allow the complex to form and bind to CCAAT sequence. Serum could also
modify a negative factor that is complexed with the CCAAT binding factor and thus
unmask the DNA binding activity of the CCAAT factor. This would be analogous to
the activation of NFkB by TPA which appears to inactivate an inhibitor of NFkB, IkB
(Bauerle and Baltimore, 1988a, 1988b). These questions can be addressed by using anti-
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bodies against CCAAT binding factors to study the proteins that are complexed with
them in serum starved and serum-stimulated cells.
A third possibility is that serum activates a regulated pathway for the uptake of
transcription factors by the nucleus. This implies the existence of active CCAAT box
binding factor in the cytoplasm of the serum-starved cell. The addition of serum either
causes the appearance of a signal on the factor (post-translational modification? induc­
tion of a co-factor?) that is recognized by the nuclear uptake machinery, or activates
some component of the uptake machinery, or represses an inhibitor of the uptake pro-
cess.
Finally, the eventual mechanism may turn out to be a combination of all or some
of the above possibilities.
The above discussion dealt only with the ways in which serum can induce nuclear
CCAAT box binding factor without new protein synthesis. However, as the results in
Table 2 make evident, the magnitude of the induction is greater in the presence of pro­
tein synthesis, raising the possibility that serum might also stimulate the synthesis of
new CCAAT box binding factor, perhaps by increasing the amount of CTF mRNA
analogous to the stimulation of transcription of the API gene by EGF (Quantin and
Breathnach, 1988).
Is the induction by serum related to the cell cyclef
There was always the possibility that the RSV LTR is active only in one phase of
the cell-cycle, and the addition of serum stimulates the expression from the LTR only
because it stimulates the cells to move through the cell-cycle. We ruled out this possibil­
ity by adding aphidicolin to 5 ,ug/ml to the serum-starved cells before adding serum.
There was no decrease in the stimulation of NEO transcripts (from RSVNEO) in the
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presence of aphidicolin (data not shown), thus indicating that the RSV LTR is stirnu­
lated by the GO-G 1 transition and does not require the cells to enter the S phase.
Which component of serum is responsible for the induction?
It had been reported that the seru� requirement of chicken fibroblasts could be
partially met by feeding the cells with high doses of insulin (Temin, 1967b). In our
hands, CAT expression from RSVCAT in serum starved 3Yl could be partially restored
by insulin or insulin like growth factor 1 (IGF1) or epidermal growth factor (EGF) but
not to the full extent obtained with 10% calf serum (data not shown). All of these
polypeptide growth factors bind to receptors on the cell surface and activate their tyro­
sine kinase activities. We have also observed a stimulation of RSVNEO mRNA in serum
starved 3Y1 upon treatment with orthovanadate and this occurred in the presence of
cycloheximide (data shown in the next chapter). Orthovanadate has been shown to inhi­
bit tyrosine phosphatases and increase the level of phosphotyrosine in cells (Klarlund et
al., 1985; Yonemoto et al., 1987). Finally, as shown in the next chapter, the tyrosine
kinase, v-src, can relieve the requirement for serum and increase the amount of nuclear
CCAAT box binding factor. All these lines of evidence point to the polypeptide growth
factors in the serum which stimulate tyrosine kinases in the cell, e.g. IGF 1, EGF, insulin,
platelet derived growth factor (PDGF) etc., as being primarily responsible for the stimu­
latory action on the RSV LTR. This hypothesis is strengthened by the reported stimu­
lation of the serum-response factor (SRF) that is responsible for the serum-induction of
c-fos, not only by serum, but also by EGF and insulin (Prywes and Roeder, 1987; Fisch
et a1., 1987; Stumpo et a1., 1988).
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Are both the C CAAT boxes in the RSV LTR equally important in serum­
induction! Are there other elements in the LTR that may playa role!
The difference in the activities of pm140CAT and �SMI40CAT is of interest in
addressing this issue. If, as has been proposed, a single DNA binding factor cannot pro­
vide a complete activation domain for the basic transcriptional machinery (Ondek et aI.,
1988), then it is conceivable that nuclear factors that bind to the SM fragment could
interact with a CCAAT factor binding to the promoter proximal ("80") CCAAT box to
provide a complete "activation domain" without requiring the presence of a CCAAT fac­
tor at the distal ("140") box. Such a complex could account for the relatively normal
activity of pm140CAT and �PSCAT. In contrast, in the absence of the SM fragment, it
becomes imperative that the LTR bind at least two CCAAT box factors to provide a
complete activating domain for the basic transcriptional machinery, accounting for the
low activity of �SMI40CAT. Thus each CCAAT box can be seen as being the
equivalent of an "enhanson", the loss of either of which can be partially compensated for
by the SM fragment.
Another intriguing observation is the increased activity of dpm814CAT relative to
pm80CAT, particularly' because pm140CAT provides no evidence to suggest that the
distal CCAAT box binds a repressor. Here too, the effects of similar mutations on the
constructs that did not have the SM fragment was instructive. Since �SM814CAT did
not have a higher level of activity compared to �SM80CAT, we can conclude that the
apparent inhibitory effect of the distal ("140") CCAAT box in pm80CAT required the
presence of an intact SM fragment. It can be envisaged that in pm80CAT, the factor(s)
binding to the SM fragment could interact with the basic transcriptional machinery at
the TATA box, but only by looping or twisting of the DNA at the "140" CCAAT box
area and this is interfered with by a CCAAT factor bound to this segment of DNA.
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Hence the apparent inhibitory effect of this CCAAT box shows up in the comparisons of
pm80CAT and dpm814CAT. That the same sequence (and possibly, the same factor)
can act as an activator in one context and repressor in another context adds to the
diversity of transcriptional control that can be achieved with various permutations and
combinations of a limited set of transcriptional factors and their binding sites.
Which CCAAT factor binds to the RSV LTR?
Many different CCAAT box factors have been identified by binding to CCAAT box
oligos, and some have even been cloned (Dorn et al., 1987; Landschulz et al., 1988; San­
toro et al., 1988; Paonessa et al., 1988; Gil et al., 1988; Chodosh et al, 1988a; Hatamochi
et al., 1988). Our finding that a CCAAT factor belonging to the CTF /CP class binds to
the RSV LTR over the two CCAAT boxes is in concordance with the reported ability of
CBF obtained from rat liver to footprint on the RSV LTR, over both the "80" and
"140" CCAAT boxes (Hatamochi et al., 1988; Maity et al., 1988). In our hands, the SM
fragment could not compete for the factor binding to the RS fragment (data not shown)
which would also conform with the results of Ryden et al.(1989) who found a different
CCAAT factor, C/EBP, footprints over the enhancer in the SM fragment.
In parallel experiments, using nuclear extracts from HeLa cells, we found that a
similar factor binds to the RS fragment through the two CCAAT boxes (data not
shown). Methylation interference assay using this extract, revealed the contact points
shown in Fig. 7. This pattern resembles that of CP2 (Chodosh et al., 1988a). Further­
more, the only bases outside the CCAAT sequence that are common between the oligos
that competed for the RSV CCAAT factor and are different from the NF 1 oligo (which
does not bind the factor as effectively) are shaded, and it can be seen that the consensus
sequence for CP2 contains the purine (R) at the 5th position 3' to the CCAAT, in con­
trast to the other consensus sequences. These two observations suggest that the factor
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that we have identified may be related to CP2.
Are these findings with mammalian cells and the isolated LTR applicable to
the intact retrovirus infecting chicken embryo fibroblasts?
As pointed out in the introduction to this chapter, there are reports in the litera­
ture which suggest that serum is important for the replication of the avian retrovirus in
CEF. Two complicating factors must be borne in mind.
The first involves the changes imposed by the presence of a transforming oncogene,
e.g. v-src, We have evidence suggesting that v-src can eliminate the serum requirement
of the RSV LTR (Chapter 3). Bell et al. (1975) reported a drop in virus titer upon
serum deprivation of a ts src infected culture of CEF held at the non-permissive tem­
perature. The absence of any such drop upon serum deprivation of a wild type RSV
infected culture when the medium was supplemented with NaHC03 (Leong et al., 1972)
must have been due to the active v-src in the latter case. Further, Chen et al. (1974)
showed that the levels of RNA and proteins from endogenous viruses in uninfected CEF
was stimulated 4-5X upon serum-stimulation of serum-deprived cultures. It is interest­
ing that though the LTR of one of the endogenous viruses, RAV-O, is smaller than that
of RSV, and lacks a strong enhancer, it still contains a CCAAT box in the antisense
strand at position -94 relative to the cap site (Hughes, 1982). Finally, in td107 infected
CEF (these viruses have the same LTR as RSV, but do not contain an active v-src), we
have found a 3-4x stimulation, of steady state levels of viral RNA upon addition of serum
to a serum-deprived culture and, as in mammalian cells, no protein synthesis was neces­
sary for the serum stimulation (data not shown). In this light, the data presented by
Humphries and Temin (1974), where they find no decrease in virus titer when ts NY68
RSV infected CEF at the NP temperature were made stationary by depleting the
medium of "multiplication stimulating activity" (MSA), could be interpreted as suggest-
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ing that the MSA deprived medium still contained serum factors that allowed viral tran­
scription to continue.
An additional complication with CEF lies in the variation from embryo to embryo.
We have found, by transfecting RSVCAT into various cultures of CEF, that some cul­
tures are less dependent on serum than others. The reason for this variation is unclear,





In this chapter, we confirm the second part of the hypothesis outlined at the begin­
ning of the last chapter, namely that the transformation of a cell by v-src relieves the
serum requirement of transcription from the RSV LTR. We demonstrate that the effect
is not due to the secretion of extracellular growth factors that substitute for serum and
that the effect of v-src is mimicked by nonspecifically stimulating the level of phospho­
tyrosine in the cells by exposing them to an inhibitor of tyrosine phosphatases, sodium­
orthovanadate. The serum inducible nuclear CCAAT binding factor that was shown to
be important for the serum induction of transcription from the RSV LTR, is also shown
to be induced by v-src, probably accounting for the serum independence of transcription
from the RSV LTR in v-src transformed cells.
MA TERIALS AND METHODS.
Cells and viruses.
3Y1 is an immortalized line of cells derived from rat fibroblasts.
tsNY 68 and tsNY 72 were prepared from molecular clones of the respective viruses
as described (Nishizawa et al. 1985, Mayer et al. 1986). The viruses were pseudotyped
by co-infecting chicken embryo fibroblasts (CEF) with either one of the ts viruses at 370
C (permissive temperature for transformation of CEF) and a transformation-defective
variant of Schmidt-Ruppin subgroup D (this subgroup can infect mammalian cells). The
medium from the fully infected cultures, containing ts src virus pseudotyped as sub­
group D, was used to infect 3Y1 in 10. % Fetal calf serum containing DEM (10% FCS
 
- 40 -
DEM). The cells were maintained at 320 C and in about ten days foci of transformed
cells could be seen. These were isolated using cloning cylinders, grown up, tested for a
temperature sensitive phenotype by growing them at 390 C, and recloned by dilution in
multiwell tissue culture plates. Most of the experiments were done with a line called ts
src 3Y1 derived from ts NY 68.
SR-3Y1 was derived from 3Y1 by transformation with wild type SR-RSV (Kawai et
aI., 1980). Most of my experiments were done with a clone derived from a colony in soft
agar which maintains its transformed phenotype consistently in 5 % calf serum contain-
ing DEM (5% CS DEM).
ts src 3Y1 was transfected with 5 ug RSVNEO linearized at a unique Bam HI site
that is outside the transcription unit of RSVNEO, and G418 resistant colonies were
selected and pooled to prepare the cell line used in Fig. 11.
Immunoblotting.
ts sr c 3Y1 were maintained in 10 % FCS DEM at 390 C for 48 hrs. After changing
the medium, the cells were shifted down to 340 C and harvested at the indicated time
points. The procedure was as described in Hamaguchi et al. 1988. Briefly, the cells were
washed in ice cold Tr is glu, scraped off the plate, pelleted, and frozen in dry ice-ethanol.
They were resuspended in Sol buffer (10 mM Tris HCl pH 7.4, 1 % SDS, 1 mM sodium
orthovanadate, 0.1 mM sodium molybdate, 1 mM PMSF) and heated to 1000 C for 5
mins.. Protein concentration was assayed by the Bio-Rad dye binding assay, and 100 J.lg
of proteins was analyzed per lane by SDS-7.5% polyacrylamide gel electrophoresis. The
proteins were transferred electrophoretically onto a nitrocellulose membrane with a
transfer buffer (25 mM Tris glycine, p H 8.6, 20% methanol) and stained with anti-PTYR
antibody (raised against bacterially expressed v-abl and purified with PTYR coupled
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Sepharose) followed by 1251 labeled protein A (Amersham).
Northerns, Sl analysis, transfections, CAT assays, nuclear extracts and gel
retardation assays.
These were performed as described in the previous chapter.
-41a-
FIGURE 8.
(A) (Upper picture) Serum-dependence of protein synthesis in 3Yl cells and
serum-independence of SR-3Yl (SR) cells. "-": 48 hrs. in 0% DEM after transfection of
RSVCAT. "+": 48 hrs. in 5% CS DEM after transfection of RSVCAT. sp: sparse cul­
ture of 3Yl; 5xl05 cells plated per 60 mm dish, 12 hrs. before transfection. d: dense cul­
ture of 3Yl cells; these were plated at the same density as above, but were allowed to
grow for 3 days, by which time they had reached saturation density.
(B) (Lower picture) Serum-independence of protein synthesis of SR-3Yl cells is pri­
marily an intra-cellular effect. For details of the experiment, see the text. "Transf":
cells that received RSVCAT. "Mixed with": cells, not containing RSVCAT, which were
mixed with the "Transf" cells, to test whether they could confer their own phenotype on
the "Transf" cells. "U": untransformed 3Yl cells. "T": transformed SR-3Yl cells. "0":




















Serum independence of protein synthesis of v-sre transformed cells is primarily
an intra-cellular effect.
Transfection of RSVCAT into 3Y1 cells, followed by 48 hrs. in the presence or
absence of 5% calf serum resulted in CAT activity per plate which was 5-10 fold greater
in the presence of serum than in its absence (Fig. 8A). In contrast, the CAT activity
from v-src transformed 3Y1 (SR-3Y1) was not significantly different in the presence or
absence of serum. The total protein content in the lysates from 3Y1 was greater by 2-5
fold in the presence of serum than in its absence, while in SR-3Y1 there was no
difference in the protein contents. This implies that the effect of serum on CAT expres­
sion from the RSV LTR is a reflection of the serum dependence (or independence) of
total protein synthesis in 3Y1 (or SR-3Y1).
To determine whether the serum independence of protein synthesis in SR-3Y1 was
due to the production of extra-cellular serum -substituting growth factors by the
transformed cells, the crossfeeding experiment in Fig. 8B was done. RSVCAT was
transfected into the indicated cell lines, which were then washed, trypsinized, pooled,
counted and equal aliquots were mixed with equal numbers of the indicated cell lines,
and replated in 5% CS DEM. After 12 hrs., the plates were washed with Tris-glu, and
fed with either 0% DEM or 5% CS DEM. 30 hrs. later, the cells were harvested and the
CAT activity per plate determined. It is clear from the results, that co-culturing 3Y1
with SR-3Yl did not confer serum independence to the 3Yl cells, nor did it inhibit the
serum independence of SR-3Y1 cells. The conclusion is that the serum independence
produced by v-src is primarily an intracellular effect.
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FIGURE 9. The ts v-src 3Y1 cell-line.
(A) Morphology of ts v-src 3Y1 at the NP temperature (390C) for 72 hrs., and 14
hrs. (P-14) and 48 hrs. (P-48) after shift-down to P temperature (34°C).
(B) Western blot of proteins with antiphosphotyrosine (anti PTYR) antibody. The
. °
protein lysates were from 3Y1, SR-3Y1 (SR), ts v-src 3Y1 at 34 C (P), ts V-STC 3Y1 at
39°C for 48 hrs. (NP), and ts v-src 3Y1 at the times indicated after shift-down from NP
to P in 10% FCS DEM. The lanes under "CH; O%S" were obtained from ts v-src 3Y1
at the NP temperature for 48 hrs., which were transferred to 0% DEM with 50 J.lg/ml
cycloheximide and then kept at the temperatures indicated for the times shown before
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Temperature-sensitive v=src transformed 3Yl line.
To test the effect of v-src, we created a ts v-src transformed 3Yl cell line where we
could switch the transforming activity of v-src on or off as needed. Fig. 9A shows that
the cells demonstrate morphological transformation upon shift from the non-permissive
(NP) temperature (39°C) to the permissive (P) temperature (34°C). Fig. 9B shows a
Western blot analysis of protein lysates from the ts src transformed cells using anti­
PTYR antibody. There is much more phosphotyrosine (PTYR) containing protein at
the P temperature than at the NP temperature, though not as much as in the wild type
v-src transformed SR-3Yl (lane 2). Upon shift down to 34° C there is a progressive
increase in PTYR containing proteins. The 60 kd PTYR containing protein is likely to
be pp60v-src. When the shift down is carried out in 0% DEM in the presence of
cycloheximide, an inhibitor of protein synthesis, there is still an observable increase in
PTYR containing proteins (compare NP 8h with P 8h in the +CH lanes). This would be
expected because the shift-down allows the pre-existing v-src protein to regain its
activity and thereby increase the PTYR content in the cells without needing to syn­
thesize new v-src.
v-src stimulates the levels of viral RNA in the presence and absence of serum.
The ts 3Yl contains full length viral RNA and the spliced env and src RNAs, all of
which initiate in the 5' LTR. Fig. 10 shows changes in the levels of the v-src RNA in
these cells under various conditions. Though only the v-src mRNA is shown, the full
length viral RNA and the env RNA behave in a similar manner. Cells grown at the NP
temperature in 5% FCS DEM for 72 hrs., were washed with Tris-glu and fed with either
0% DEM or 5% FCS DEM and incubated for the indicated lengths of time at the NP
temperature (390C) or the P temperature (340 C). The v-src mRNA level dropped
-43a-
FIGURE 10. Active v-src relieves the serum requirement of the RSV LTR and stimu­
lates the levels of viral transcripts.
Northern blot of RSV RNA from-the ts v-src 3Yl cells under various conditions.
Upper panels: v-src RNA. Lower panels: Ethidium bromide stained filter to show equal
transfer of RNA in all lanes. "Oh": ts v-src 3Yl cells in 5% FCS DEM at 390C (NP) for
72 hrs. Left panel: "Oh" cells kept at 390C after changing medium (0% DEM or 5%
FCS DEM, as shown) and harvested at the times (in hrs.) indicated. Right panel: Same
as left panel except plates were maintained at 340C (P) after medium change. A lighter
exposure of the right panel is shown to avoid loss of resolution in the 48 hr. lanes. The 0


















rapidly in 0% DEM and 5% FCS DEM at the NP temperature. However, once the tem­
perature is lowered to activate the tyrosine-kinase activity of ts v-src, it can be seen
(Fig. 10 Rt. hand panel) that active v-src relieves the serum requirement for mainte­
nance of viral RNA levels (the continued persistence of v-src RNA in 0% DEM at the P
temperature).
It is also of interest to note that the level of the viral RNA appears to be stimu­
lated by the tyrosine kinase activity of v-src. This is evident from the progressive
increase in the level of the v-src RNA with increasing time after shift-down, and the
greater quantity of the RNA at the P temperature, compared to that at the NP tem­
perature, at every time-point, both in the absence and presence of serum.
The drop in the viral RNA level at the NP temperature even in the presence of
serum, might suggest that the effect of serum on the level of viral RNA, at the NP tem­
perature, is short-lived. This is consistent with our observation that in untransforrned
3Yl cells, the addition of serum to a serum-deprived culture causes an elevation of LTR
directed RNA levels that starts declining between 5 and 10 hrs after the stimulation
(Fig. IB).
Serum sparing effect of v-src on the levels of RNA transcribed from the RSV
LTR is seen in the absence of new protein synthesis.
Since there is some increase in PTYR containing proteins III the ts src 3Yl cells
upon shift down in the presence of cycloheximide, in the absence of serum (Fig. 9), it
was possible to test whether the serum-sparing effect of v-src was exerted without
requiring new protein synthesis. The experiment is limited by the toxicity of cyclohexi­
mide in 0% DEM on the ts src 3Yl at the NP temperature. Under these conditions, the
cells remain viable upto about 12 hrs.. Using RSVNEO stably integrated into the ts src
3Yl, the level of transcripts initiating at the LTR was measured by an 81 Nuclease
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FIGURE 11. Serum sparing effect of v-src is seen on the isolated RSV LTR and in the
presence of cycloheximide.
SI nuclease analysis of transcripts from RSVNEO in ts v-src 3Yl cells containing
RSVNEO stably integrated in the genome. The probe was RSVNEO cut and end­
labelled at an unique Nco I site in the body of the NEO gene. Transcripts correctly ini­
tiated in the RSV LTR protect the 950 base long fragment shown. Left 3 lanes: cells
grown in 10% FCS DEM at the NP temperature for 72 hrs. were transferred to 0%
DEM (lane 0), and maintained at the NP temperature for 8 hrs. (N8) or the P tempera­
ture for 8hrs. (P8) before harvesting their total RNA for analysis. Right 3 lanes: same as
above, except that cycloheximide at 10 J.lg/ml was added at the time of medium change.
+CH
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assay (Fig. 11). Serum depletion of the cells at the NP temperature resulted in a discer­
nible decline in the amount of NEO transcript by 8 hrs. (lane N8 vs lane 0). The serum
sparing effect of the active V-STC can be seen in a parallel culture held at the P tempera­
ture (P8). Addition of cycloheximide to 10 J.lg/ml to the plates at 0 hr. caused a two
fold increase in the level of NEO transcripts (this is also seen in 3Yl, Fig. 1). However,
the serum sparing effect of V-STC was still evident even though new protein synthesis was
blocked (compare lanes N8 and P8 under +CH).
V-STC induces nuclear CCAAT binding faetor.
In the preceding chapter, it was shown that a CCAAT box binding factor belonging
to the CTF /CP class, binds to the RSV LTR and mediates the serum responsiveness of
the LTR. In view of the serum-sparing effect, and the stimulatory effect, of the tyrosine
kinase activity of V-STC on the level of RNA from the RSV LTR (Figs. 10 and 11), it. was
worthwhile to examine what effect v-src had on the nuclear CCAAT box binding factor
that binds to the LTR.
Nuclear extracts were prepared from the ts sr c 3Yl growing at 390C (NP) or 34°C
(P) for 72 hrs., in 10% FCS DEM, which was changed every 24 hrs.. The relative
amounts of CCAAT box binding protein were measured using equal quantities of nuclear
extract proteins in a gel retardation assay with the PS fragment (Fig. 2) of the RSV
LTR (Fig. 12). Comparing lanes 1 and 3 leads to the conclusion that the active v-src at
the P temperature induces the LTR CCAAT factor. In this experiment, both the bands
seen in the gel shift assay (bands 1 and· 2 : Fig. 5, Table 2) were visible and both were
increased. Nuclear extracts from 3Yl (not containing a v-src oncogene), grown at 390 C
and 340 C under identical conditions, did not show any difference in the relative
amounts of CCAAT binding factor (data not shown).
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FIGURE 12. V-src stimulates the level of nuclear CCAAT factor.
Gel mobility shift assay using radio-labelled PS fragment (contains the distal
CCAAT box of the LTR). Alternate reactions contain a plasmid carrying the intact PS
fragment (pAD5) or a PS fragment with a mutation in the CCAAT box (pAD5pm1) as
indicated. Only the specific DNA-protein complexes are shown (2 bands are seen in the
experiment in the upper panel, while only the lower band is seen in the experiment in
the lower panel). The nuclear extracts used in the upper panel are from ts v-src 3Y1
cells in 10% FCS DEM kept at 3g0C for 72 hrs. (N 72, lanes 1 and 2), or at 34°C for 72
hrs. (P72, lanes 3 and 4). For the lower panel, the ts v-src 3Y1 cells grown in 10% FCS
DEM at 3g0C for 72 hrs. (N 72 conditions), were incubated for another 100 hrs. either at
3g0C (N-- > N, lanes 5 and 6) or at 34°C (N-- > P, lanes 7 and 8) before preparing
nuclear extracts.
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Ts src 3Y1 growing at the NP temperature for 72 hrs. were either maintained at
the NP temperature, or shifted down to the P temperature, and incubated for another
100 hrs., with the medium being changed every 36 hrs.. Nuclear extracts were made
from these cells and equal quantities of protein were used for a gel shift assay. In this
experiment, only the lower of the two bands (band 1) is seen, and it is induced strongly
by the re-activated v-src at the P temperature (lane 7 compared to lane 5).
Orthovanadate stimulates transcription from the RSV LTR in serum starved
cells.
v-src could be rendering the cells serum-independent by activating signal­
transduction pathways that normally are activated only by extracellular growth factors
present in the serum. An obvious mechanism would involve the tyrosine-kinase- activity
of v-src mimicking the tyrosine kinase activity of growth factor receptors interacting
with their cognate ligands (e.g. insulin receptor, insulin like growth factor I (IGFI)
receptor, EGF receptor, PDGF receptor etc.). If this was the case, then it could be
predicted that non-specific elevation of PTYR content in untransformed 3Y1 would have
a serum-mimetic effect on transcription from the RSV LTR.
Fig. 13A shows the effect of adding sodium-orthovanadate to a serum-deprived cul­
ture of 3Yl containing RSVNEO integrated into the cellular genome. The levels of NEO
transcripts were followed by using equal quantities of total cellular RNA in a slot-blot­
analysis and probing with a fragment from the NEO gene. A 10 fold stimulation of
steady state level of NEO RNA was induced by 150 JLM sodium-orthovanadate.
Further, at least part of the stimulation persisted in the presence of an inhibitor of new
protein synthesis (cycloheximide). Fig. 13B shows that most of the effect of orthovana­
date on the RSVNEO transcript could be accounted for by a stimulation of transcription
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FIGURE 13. Orthovanadate mimics the effects of serum and v-src on the RSV LTR.
(A) Slot blot analysis of NEO transcripts from RSVNEO stably integrated into the
genome of 3Yl. After serum deprivation (0% DEM) for 48 hrs. (0 hr.), the cells were
exposed to 150 J-LM sodium orthovanadate and total RNA prepared at the times indi­
cated. 3 J-Lg RNA was used per slot (V). In a parallel experiment, cycloheximide was
added to 50 J-Lg/ml before adding vanadate. 1 J-Lg RNA was used per slot (CH+V). All
the signals were quantitated by densitometry of the autoradiograms, normalized to the
signal from the 0 hr. (V) point and plotted.
(B) Nuclear run on analysis of the cell-line used above. Radiolabelled run-on tran­
scripts were prepared from cells that were in 0% DEM for 48 hrs. (0) and from parallel
cells that were exposed to 150 J-LM sodium orthovanadate for an additional 6 hrs. before
harvesting. The blots contained the probes indicated (for details, see MATERIALS &
METHODS of Chapter 2).
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(as measured by nuclear run-on assay) from the R8V LTR. The run-on assay also shows
that the effect of orthovanadate on the R8V LTR was not part of a generalized, non­
specific effect on transcription, because the promoters for c-fos, {3 tubulin and 288 ribo­




How does v-src confer serum independence?
The results presented in Figs. 8A and 10 suggest that v-src transformed cells do
not require serum to drive the expression of a gene by the RSV LTR. There have been
other instances where the transformation of a cell by an oncogene confers the ability to
grow independent of certain extracellular growth factors. v-src transformed fibroblasts
require less serum (Hanafusa, 1977) and appear to not require EGF and Fibroblast
growth factor (FGF) (Giguere and Gospodarowicz, 1983). v-src and related tyrosine
kinase oncogenes also make chicken myeloid cells independent of chicken myelomono­
cytic growth factor (cMGF) (Adkins et al., 1984). v-abl, another tyrosine kinase
oncogene, transforms fibroblasts and makes them independent of PDGF (Rees-Jones et
al. 1989), erythroblasts of erythropoietin (Waneck et al. 1986), lymphoid cells of IL-3
(Mathey-Prevot et al. 1986) etc ..
In some of the instances cited above, the factor-independent cells are found to
secrete a protein into the extracellular medium accounting for the independence from
exogenously added factor. Examples of this may be found in the secretion of transform­
ing growth factor alpha and beta by v-mos transformed fibroblasts (Anzano et al., 1983),
PDGF like molecules by a variety of transformed cells (Bowen-Pope et al., 1984), etc ..
Upon transformation by v=sr c, myeloid cells produce cMGF (Adkins et al., 1984) and
3T3Ll murine fibroblasts produce a TGF beta like factor and a protease sensitive mito­
gen (Langer-Safer et al., 1985) that are detectable in the extracellular medium. In other
instances, there does not appear to be an extracellular factor that can be detected in
media conditioned by the transformed cells (Daley and Baltimore, 1988; Hariharan et al.,
1988). The result presented in Fig. 8B supports the view that the serum-independence
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of RSV LTR directed gene expression is primarily an intracellular effect.
The effect of v-src may involve the production of a growth factor inside the cell
which stimulates its cognate receptor (intracellularly) and thus renders the cells serum­
independent. Such may be the case with PDGF and the human osteosarcoma cell line
U-2 OS CL 6 (Betsholtz et at, 1984) or IL-3 and bcr-abl transformed myeloid cell line
FDC-Pl (Hariharan et at, 1988). However, in view of the serum sparing effect of v-src
in the presence of cycloheximide (Fig. 11), we favor the hypothesis that v-src directly
turns on the pathways that are normally stimulated by serum in 3Yl cells.
What pathways could these be? Since some of the effects of serum can be partially
mimicked by insulin, IGFI or EGF (preceding chapter, data not shown), all of which
exert their actions through the tyrosine kinase activities of their receptors, the predom­
inant signal transduced from serum (and activated by v-src) need not involve a single
substrate but could involve an increase in the amount of PTYR on several key intra­
cellular proteins activating multiple signal transduction pathways. The stimulation of
transcription from the RSV LTR by orthovanadate, which inhibits phosphotyrosine
phosphatases and nonspecifically increases the amount of PTYR on cellular proteins,
supports this argument. An inhibitor of protein synthesis does not completely block the
activation of transcription by vanadate, confirming that elevation of PTYR in the cells,
whether by v-src o�. orthovanadate, directly sends the signal to the nucleus and argues
against the signal being mediated by the synthesis of an intracellular growth factor.
How is the nuc.lear CCAAT box binding factor induced by v-src?
In the preceding chapter it was shown that the final effector of the signal trans­
duced from serum to the RSV LTR in the nucleus could be a nuclear CCAAT box bind­
ing factor. This factor was induced by serum with a time course similar to the induction
 
- 50 -
of transcription from the RSV LTR, the induction of the factor occurred in the presence
of cycloheximide (as was the induction of transcription), and mutations in the LTR that
blocked the binding of the factor also blocked the serum induction of transcription from
the LTR.
Fig. 12 shows that this same factor is induced by v-src in the presence of serum,
providing a possible mechanism for the increased level of LTR directed mRNA synthesis
seen in ts src 3Yl at the permissive temperature (Fig. 10). Could an induction of the
same CCAAT factor by v-src be responsible for the serum-sparing effect of the
oncogene? We believe it could, because nuclear extracts made from 3Yl cells show a
rapid depletion of the CCAAT binding factor upon serum-deprivation while extracts
from SR-3Yl cells retain the CCAAT binding activity under identical conditions (data
not shown).
The experiment to check if v-src could induce the CCAAT factor in the absence of
protein synthesis turned out to be complicated by (a) the lower level of v-src kinase
activity in the ts src 3Yl cells compared to the wild type v-src transformed 3Y1 (SR-
3Y1) (Fig. 9) and (b) the slow increase in tyrosine-kinase activity upon shift down to the
permissive temperature (Fig. 9). Within the time period that the ts src 3Yl at the NP
temperature (the "no src" control) remains viable after the addition of cycloheximide,
the net increase in kinase activity was barely sufficient to produce a 2 fold difference in
the levels of RSV LTR directed transcripts (Fig. 11). A 2 fold (probably less) difference
in the level of the nuclear CCAAT factor would not have been discernible in the nuclear
extracts that were prepared. However, in view of the ability of serum to induce the
CCAAT factor in the presence of cycloheximide (previous chapter), and the ability of v­
sr c (Fig. 11) and vanadate (Fig. 13) to exert their serum-mimetic effects on the RSV
LTR in the presence of cycloheximide, it appears likely that the tyrosine-kinase activity
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of v-src would be able to induce nuclear CCAAT factor without needing new protein
synthesis.
This does not rule out an additional effect of v-src on the CCAAT factor mediated
through the synthesis of new proteins. In fact, the slow and progressive increase of LTR
driven gene expression upon shifting the ts src 3Y1 cells to the permissive temperature,
suggests that at least some of the effect of v-src on the LTR is not a primary effect. One
could imagine a scenario where the initial increase in nuclear CCAAT factor induced by
post-translational mechanisms leads to changes in transcription of genes coding for vari-
ous components on the signal transduction pathway. If protein synthesis is allowed to
proceed, then these new transcripts would be translated, resulting in more profound
changes in cellular physiology. One obvious candidate for such a protein would be v-src
itself. In fact, the slow and progressive increase of the pp60
v-src band upon shift-down
(Fig. 9) supports this view. A second candidate for such a protein would be the CCAAT
factor itself. Gel retardation analysis of nuclear extracts prepared at various times after
shifting ts sr c 3Y1 cells to the P temperature, shows a discernible difference in the levels
of CCAAT factor per J1.g of nuclear protein between the NP and P cells only after 24 -
36 hrs. (data not shown), and this slowly increases to the difference seen at 100 hrs. after
shift down (Fig. 12), implicating a slow mechanism in the induction of the CCAAT fac-
tor. Could this, involve induction of the gene for the CCAAT factor itself? This
".
hypothesis can be tested easily using cloned CCAAT factor (CTF or NF 1) (Santoro et
al., 1988; Paonessa et al., 1988; Gil et al., 1988) as a probe on the Northern blots of Fig.
10.
What could be the mechanisms by which v-src induces nuclear CCAAT factor?
The models suggested for serum induction of the CCAAT factor (in the preceding
chapter) are equally applicable for induction by v-src. The common mechanism between
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the two pathways, as also for the induction by orthovanadate, would be an increase in
the PTYR content of critical cellular proteins.
Are the effects of V-STC on the RSV LTR in rat cells relevant to RSV infection
of CEF?
In tsNY68 or tsNY72 infected culture of CEF, when total cellular RNA was har­
vested at various times after shift-down to the permissive temperature, and the RNA
examined by Northern blot analysis, we found a 3-4X increase in the levels of all the
viral RNAs within 0.5-1 hr. after shift-down (data not shown). This corresponds well to
the rate of increase of PTYR containing proteins after shift-down (Hamaguchi et al.,
1988). However, the elevation in the level of viral RNA did not persist, having decreased
to levels below that found in parallel cultures held at the NP temperature by 6-12hrs ..
This is in contrast to the result with the ts STC 3Yl (Fig. 10) and could be due to detri­
mental effects of increased viral replication and spread on the CEF. It is of interest that
a similar feature of induction followed by return to NP levels is seen with several other
V-STC induced messages in CEF (Simmons et al., 1989).
The effect of orthovanadate on the level of viral RNA in serum deprived CEF,
infected with tdl07 (a transformation defective variant of RSV), is identical to the effect
on RSVNEO in 3Yl shown in Fig. 13 '�ata �ot shown).
Finally, if V-STC had a stimulatory effect on expression from an avian retroviral
LTR in CEF, particularly a serum-sparing effect, then it would resolve the contradiction
in the literature between the results of Leong et al. (1972), who found no drop in the lev­
els of virus titer upon serum deprivation of cells that are already transformed by SR­
RSV (provided that the p H of the medium was maintained by adding NaHC03) and
those of Bell et al. (1975), who found a 100 fold drop in titer of infectious virus upon
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It is progressively becoming evident that the transcriptional machinery of
eukaryotes has been preserved such that there are many components in common
between species as divergent as Saccharomyces cerevisiae and Homo sapiens. The
steroid receptors and their transcriptional response elements from humans work in yeast
(Schena and Yamamoto, 1988; Metzger et al., 1988). The bacterial repressors and opera­
tors work in yeast and in animal cells (Brent and Ptashne, 1984; Hu and Davidson, 1987;
Brown et al., 1987; Figge et al., 1988). Several yeast transcriptional factors appear to be
homologous to factors in animal cells, e.g. GCN4 and API (Struhl, 1987; Harshman et
al., 1988), HAP2/HAP3 and the CCAAT box binding factors of HELA cells (Chodosh et
al., 1988a, 1988b) and yeast PRTF /GRM and the c-fos SRF (Norman et al., 1988).
GAL4, a yeast transcription factor works in animal cells (Kakidani and Ptashne, 1988;
Webster et al., 1988). Even biochemically purified TATA box binding factor from yeast
directs transcription in vitro using a HELA cell transcription extract (Buratowski et al.,
1988; Cavallini et al., 1988).
In this light, we examined whether the RSV LTR 'directs transcription in Saccharo­
myces, on the assumption that if it did, it would be an ideal system for cloning tran­
scription factors that interact with the LTR in yeast, taking advantage of the genetic
approaches available in yeast. Further, yeast would provide an ideal system for delineat­
ing various factors that interact with each other and thereby regulate the transcription
from the LTR. Finally, once yeast genes have been identified that are responsible for
regulating transcription from the LTR, it should be possible to clone the homologues
from animal cells by their ability to complement the mutations in the yeast genes.
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We find that the LTR directs accurate initiation of transcription in yeast, probably
uses the same TATA box that is used in mammalian cells, and also uses the same
CCAAT boxes as an "upstream activating sequence" (VAS). Furthermore, mutations
affecting these essential sequences gave a phenotype to the yeast carrying them, so that
it will be possible to devise selection strategies for isolating mutations in yeast transcrip­
tion factors, and possibly clone the genes for yeast and mammalian transcription factors
and do structure function analysis on them. We also tested whether V-STC stimulates the






RSVCAT, .6.SMCAT, .6.RSCAT, .6.PSCAT, pm80CAT and dpm814CAT have been
described. .6.HRCAT was made. by cutting 51BgCAT (described in Chapter 2) at the
unique Bgl II and Hind III sites, blunting with Klenow, and ligating with T4 DNA ligase.
Parental forms were selected against by cutting once again with the same restriction
enzymes, transforming E. coli and screening some of the colonies for a plasmid with the
required deletion. SV2CAT (Gorman et al., 1982a) has the SY40 enhancer and early
promoter directing expression of the bacterial CAT gene.
All the plasmids mentioned above (except 51BgCAT) were each cut at an unique
Bam HI site which is outside the CAT transcription unit, treated with Bacterial alkaline
phosphatase, and ligated with a �.9 kb Bam HI fragment encoding the HIS3 gene of Sac­
charomyces cerevisiae. Standard procedures (Maniatis et al. 1982) were used to screen
for plasmids having one 1.9 kb fragment inserted into the corresponding CAT plasmid.
The CAT plasmids with the HIS3 auxotrophic marker were named XCAT+HIS (e.g.
RSYCAT+HIS) if the directions of transcription of HIS3 and CAT were the same and
XCAT-HIS if they were opposite to each other.
pFL is derived from pBR322 and contains the "autonomous replication sequence"
(ARS) of a 2 /-lm plasmid inserted into the Eco RI site, and the yeast DRA3 gene in the
Hind III site. The 4.7 kb Bam HI to BgL I fragment of pFL is ligated to the 3.5 kb Bam
HI to Bgl I fragment of RSYCAT to give FRSVCAT. This plasmid has a CoIE1 origin
of replication, an ampicillin resistance gene, the RSV LTR directing transcription of the
CAT gene, the URA3 gene, and the origin of replication of a 2 ).lm episome from yeast.
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YEP 51 (Broach et al. 1983) contains the yeast LEU2 gene under control of its own
promoter, a GAL 10 promoter, the origin of replication of a yeast 2 J..lm plasmid, a bac­
terial ampicillin resistance gene and a bacterial ColEI origin of replication. There are 3
Eco RI sites, one in the LEU2 gene and two flanking the 2 J..lm origin of replication. Y­
vsrc (Kornbluth et al. 1987) contains the v-src gene integrated into YEP 51 such that it
is under the control of the GAL 10 promoter. To make the integrating plasmids IP 51
and l-vsrc, YEP 51 and Y-vsrc were each partially digested with Eco RI, ligated, paren­
tal forms selected against using Xba I (which cuts once in the Eco RI fragment encoding
the 2 Jlm origin of replication), and the reaction products used to transform E. coli RRI
(leu B-) to Ampicillin resistance and LEU+. The colonies growing on minimal agar, sup­
plemented with proline and containing ampicillin, all contained the desired plasmids
with the 2 uss: ARS deleted out.
Strains and media.
The strains of S. cerevisiae used were W303-1A (haploid, MATa, ade 2-1, ura 3-1,
leu 2-3,112, his 3-11,15, trp 1-1, can 1-100), BWGI-7A (MATa, leu 2-3,112, his 4-519, ade
1-100, ura 3-52) and its derivatives hap 2-1 (Guarante, 1984) and �hap3 (Olesen et al.,
1987; Hahn et al., 1988). The yeast were grown in synthetic or YEP media containing
2% glucose, 3% lactate, 2% galactose or 2% raffinose.
Transformation of yeast, RNA and DNA analysis.
These were all done using standard protocols (Sherman et al. 1986 and Maniatis et
al., 1982). For establishing the lines of yeast containing RSVCAT and its derivatives, we
started with W303-1A. These were transformed with the CAT+HIS plasmids that had
been linearized at a Xho I site in the HIS3 gene, using the Lithium chloride treatment
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protocol, and selected on minimal medium (SD) supplemented with adenine, uracil, leu­
cine and tryptophan (his-). A few of the colonies were grown up in SD (his-) followed by
at least 15 -20 generations of growth in YPD (no selection). The yeast were then plated
at the appropriate dilution on YPD and replica plated onto SD (his-). If all the colonies
that grew up on YPD were also HIS+, the CAT+HIS plasmids were considered to be
integrated into the yeast genome.
To ensure that the yeast we studied had only one copy of the CAT gene per
haploid genome, DNA was prepared from them, digested with Eco RI and Bam HI, and
a Southern analysis was performed using nick translated RSVCAT and pTRPl (contains
the yeast TRP1 gene cloned into pUC 18).
Total RNA was prepared from the yeast by vortexing them in the presence of glass
beads, phenol and LETS buffer (0.1 M LiCI, 0.01 M EDTA, 0.01 M Tris HCI pH 7.4,
0.2% SDS), followed by phenol extraction and chloroform extraction of the aqueous
layer. S 1 analysis and Northerns were performed as described in Chapter 2.
Primer extension was done using 50 J..Lg of total RNA in 10 J..LI vol containing 50 mM
Tris HCI pH 7.5, 75 mM KCI, 10 mM DTT, 3 mM MgCI2, 0.5 mM of each of the four
dNTPs and 20 ng of CAT24 oligo (5'CTCCATTTTAGCTTCCTTAGCTCC3') labeled
at the 5' end using T4 polynucleotide kinase and J32p ATP. The mixture was heated to
850 C for 5', cooled slowly to room temperature (250 C), 200 units of MoMuLV reverse
transcriptase was added, and the primer extension was allowed to proceed for 60 mins.
at 370 C. The sequencing ladder was created by double stranded plasmid sequencing




Overnight cultures of the various strains in YPD were diluted 1:5 in fresh YPD and
incubation at 300C continued for 3 hrs .. The yeast were then harvested by centrifuga­
tion, washed with water, suspended in 200 J.lI of 0.25 M Tris HCI pH 7.8, and broken by
vortexing with glass beads for 15 mins. at 4oC. The aqueous layer was collected after
spinning for 5 mins. in the microfuge at 4oC, and any particulate matter removed by a
second spin of 10 mins.. The protein content in each lysate was measured using the
Bio-Rad dye binding assay. 1 J.lg of total protein was used for the CAT assay using 0.25
J.lCi of 14C Chloramphenicol (NEN, 60 mCi/mmol) as described before (Chapter 2). The
reaction was performed at 37°C for 10 mins ..
Immunopreeipitation kinase assays.
.
150 ml of an overnight culture of each strain of yeast was grown up in 0.67% yeast
nitrogen base, 2% w[v raffinose and supplemented with adenine, tryptophan and uracil.
The cultures were pelleted and resuspended in the same volume of a similar medium
containing 2% w[v galactose instead of raffinose. Incubation was continued for 4 hrs at
300C before the cells were harvested and lysed in RIPA buffer (10 mM Tris HCI pH 7.4,
1 mM EDTA, 150 mM NaCI, 1% Triton X-lOO, 1% sodium deoxycholate, 0.1% SDS, 1
mM PMSF and 1% (v Iv) Trasylol) as described in Kornbluth et al. (1987). Immunopre­
cipitation with mAb 327 (Lipsich et al. 1983) and in vitro kinase assay were performed
as described (Kornbluth et al., 1987).
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FIGURE 14.
SI nuclease analysis of RNA from yeast carrying one copy of RSVCAT (R-Yst) or
SV2CAT (S-Yst) and from 3Yl cells transiently transfected with RSVCAT (R-3Yl).
"H3": fragment produced by cutting the probe with Hind III. The probe was RSVCAT,
cut and labelled at an unique Nco I site in the CAT gene. The sizes of the fragments
protected are correlated with a schematic of RSVCAT at the bottom of the figure. "U3,
Rand U5" are parts of the RSV LTR. SV2CAT diverges in sequence from RSVCAT
upstream of the Hind III site and so all transcripts present in "S-Yst" that initiate
upstream from this point protect the probe only upto the Hind III site. "M": size mark­


































The RSV LTR directs accurate initiation of transcription in S. cerevisiae
about 60 bases downstream from the TATA box.
Total cellular RNA was prepared from yeast containing one copy of R8VCAT
integrated at the HI83 locus in the genome. 81 nuclease analysis using R8VCAT cut
and end-labeled at the Nco I site as the probe (Fig. 14), suggested specific initiation of
transcripts near the Hind III site which is 544 base upstream from the Nco I site (com­
pare the size of the protected fragment in the R-Yst lane with the fragment generated
by cleaving the probe with Hind III). This shows that the R8V LTR in yeast may be
directing initiation of transcription about 60 bases downstream from the TATA box.
RNA from yeast containing 8V2CAT was used as a control for specificity of the 81
assay and showed a different pattern of protection (8-Yst). The smaller protected frag­
ment was probably produced by RNA initiating at a specific site in the body of the CAT
gene. The larger protected fragment is an artifact resulting from the divergence in
sequence of the 8V2CAT plasmid from the R8VCAT probe upstream from the Hind III
site. Consequently, transcripts initiating upstream of this Hind III site protect the Nco I
- Hind III (544 base) fragment. This larger protected fragment in the 8-Yst lane there­
fore marks the position of the Hind III site. Referring to this size marker in the right
hand panel of Fig. 14 clearly. indicates that in contrast to the situation in yeast, RNA
derived from transient transfection of R8VCAT into mammalian cells (3Yl) initiates at
a site about 35 bases upstream from the Hind III site. This is the authentic initiation




Primer extension analysis of RNA from yeast containing one copy of RSVCAT
(RSV) or SV2CAT (SV2). "-": no RNA added to the reaction. The primer was the
CAT 24 oligo described in the MATERIALS & METHODS and the 3' extent of it is
indicated on the sequence at the bottom of the figure. A sequencing ladder was created
using the same oligo on RSVCAT and was run alongside the primer-extension products.
The sequencing lanes are presented such that reading from bottom to top one reads the
sequence .of the sense strand of RSVCAT from 3' to 5'. The closed and open triangles
mark the specific extension products seen with the yeast containing RSVCAT and
correspond to the major and minor initiation sites respectively. On the sequence at the
bottom, the TATA box is underlined, and the major and minor transcription start sites
indicated by closed and open boxes, respectively. The numbers are relative to the tran­
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Amount of CAT expressed from various mutant derivatives of RSVCAT present in
single copy in yeast. A schematic of the RSVCAT plasmid is given at the top, and the
major transcription start site indicated with an arrow. H: Hind III, R: Eco RI, P: Pvt/, I,
S: Sph I, M: Mst II. T: TATA box. HRCAT, RSCAT, SMCAT, PSCAT are the
corresponding Ll plasmids. Gaps bounded by restriction enzyme sites indicate the
extents of the deletions, and the dots mark the positions of the point-mutations. For
the exact sequences of the point mutations, see Fig. 2. The CAT activities are given in
the units shown, along with the standard errors, and the number of independent meas­
urements.
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RSVCAT 4.2 ± 0.4 (6)
HRCAT 0.03± 0.01(3)
RSCAT 1.7S± 0.5 (6)
SMCAT 7.4 ± 0.3 (4 )
PSCAT S.4S± 1.0 (4 )
prnBOCAT 4.7 ± 0.4 (3)




To confirm this finding, a primer extension analysis was done usmg the CAT24
oligo as a primer (Fig. 15). It can be seen that the transcripts from the RSV LTR in
yeast initiate at two major sites near the Hind III recognition sequence and one minor
site further upstream. Clearly, no initiation can be seen at the beginning of R (the +1
for higher eukaryotic cells). Again RNA from yeast containing SV2CAT was used as a
control for the specificity of the RSV LTR.
The TATA box and the CCAAT boxes of the RSV LTR are required for
expression from the LTR in yeast.
The structure of the LTR was shown in Fig. 2 along with some of the point-
mutations made in the RS fragment. To determine which parts of the LTR had
demonstrable functions in directing expression from it in S. cerevisiae, The plasmids
indicated in Fig. 16 were each linked to a HIS3 gene and introduced into yeast. Results
of CAT assays performed with extracts from the yeast containing the XCAT+HIS
plasmids are shown. The deletion in �HRCAT appears to remove a very critical func-
tion of the LTR. Since the major initiation site in yeast (Fig. 15) is left intact in this
deletion, one could presume that the critical element removed is the TATA box. Exami-
nation of the sequence removed reveals only the TATA box shown in Fig. 15 as resem-
bling the canonical TATA box sequenc�s. This is the same TATA box used for tran-
"
.
scription from the RSV LTR in animal cells (Gilmartin and Parsons, 1983).
�RSCAT and dpm814CAT had half the activity of the intact RSVCAT. One con-
elusion that may be drawn is that the two CCAAT boxes in the RS fragment act as
"upstream activating sequences" (VAS). The lack of a significant decrease in CAT
activity with pm80CAT and LlPSCAT (which deletes the distal, "140", CCAAT box)
indicates that both the CCAAT sequences are functional III YPD, and either of them
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FIGURE 17.
Ability of RSVCAT and its derivatives to confer resistance to chloramphenicol.
Yeast containing one copy of each of the plasmids indicated (XCAT+HIS) were grown
on synthetic medium without histidine and with lactate as the only carbon source. They
were then spotted on agar plates with the same medium but containing chloramphenicol
at 0 mgj'rnl (top plate), 1 mg/ml (bottom left) and 2 mg/rnl (bottom right). On each
plate, the yeast containing the CAT plasmids were spotted in the following arrangement
from left to right: in the top row, RSVCAT, 6.HRCATj in the middle row, 6.RSCAT,




alone can function effectively as an VAS.
The deletions in the LTR confer a distinct phenotype to the yeast.
It has been shown that in S. cerevisiae growing on a non-fermentable carbon source
(e.g. lactate), chloramphenicol is toxic to the yeast, and that expression of chloramphen­
icol acetyl transferase (CAT) relieves this toxicity (Cohen et al., 1980). Fig. 17 demon­
strates that RSVCAT present in a single copy in the genome allows the yeast to grow on
lactate at concentrations of chloramphenicol upto 2 mg/rnl. As would be predicted, the
dHR deletion construct is unable to support growth at 1 mg'/rnl chloramphenicol, while
the dRSCAT, pm80CAT and dpm814CAT are able to confer resistance to 1 mg/rnl but
not to 2 mg/rnl chloramphenicol. The fact that the dPSCAT could confer resistance
upto 2 mgj'rnl of chloramphenicol while pm80CAT could not, implies that under these
growth conditions, the proximal CCAAT box alone is critical for the VAS function.
The products of HAP2 and HAP3 genes are not involved in transcription from
the RSV LTR in yeast.
Since the CCAAT boxes in the RSV LTR have been shown to bind specific tran­
scription factors in rat cells (chapter 2), and since it has been demonstrated that the
gene products of HAP2 and HAP3 in yeast bind to CCAAT like sequences and are
activators of transcription from severalyeast promoters (Chodosh et aI., 1988b), it was
possible that the CCAAT sequences in the LTR were binding the HAP2 and HAP3 gene
products. This possibility appeared even more likely upon observing the sequence simi­
larity of the VAS2VPI-CYCl CCAAT box and those of the RSV LTR (Fig. 18). How-
ever, two observations make this unlikely.
The genes that are activated by HAP2/HAP3 are induced when grown on a non­
fermentable carbon source (e.g. lactate) as opposed to glucose. For instance, beta-
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FIGURE 18.
Sequences of CCAAT elements that play a role in transcription in yeast. RSV80:
the promoter proximal CCAAT box in the RSV LTR. RSV140: the distal CCAAT box
in the RSV LTR. UAS2CYC1: actually the UAS2UP1-CYC1 upstream of the CYC1
promoter (Chodosh et al, 1988b). TY1 II: Block II sequence in the Ty 1 element (Com­
pany and Errede, 1988). The positions of the mutations in a Block II oligomer that inac­
tivated its "UAS" activity and its ability to bind a sequence specific DNA binding pro­
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RSVCAT-HIS O.N. culture in
minimal medium.
10 0.9
RSVCAT-HIS O.N. culture in
minimal medium.
2.5 0.3
RSVCAT+HIS O.N. culture in
YP diluted l: 5
grown for 3 hrs.
4.0 0.02
1. Yeast containing one copy of the indicated plasmid integrated
into the genome were used.
2. O.N. : overnight saturated cultL�e.


















S. Lactate. O.N. 1.6 0.8 0.3
s. Glucose. O.N. 1.6 1.8 0.6
or
YEP 51 2.0
s. Raffinose. O.N. 2.7 0.5





O.N. 1:1 Y.Glu. 1.04
1:5 Y.Gal. 1.11
1:1 Y.Gal. 0.84
S. Glu 1:1 S.Glu. 1.0
1: 1 S.Gal. 2.3O.N.
1. Yeast containing one copy of the CAT plasmid were used.
The yeast also contained either one of the rnulticopy episomal Y
plasrnids shown or one of the integrated I plasrnids.
2. S: Synthetic rnediwn with appropiate additions to maintain
selection for the plasrnids. Y: YEP rnediwn. Glu: glucose. Gal:
galactose. O.N. : overnight saturated cultures (at least 16 hrs.)
in the indicated rnediwn.
3. In the bottom half of the table, the O.N. cultures
indicated are pelleted, washed and resuspended in the media shown
at the dilutions shown and allowed to incubate with shaking for 3
hrs. before harvesting.
4. The ratios of the % chloramphenicol acetylated per minute
per microgram of protein extract from yeast containing Y-vsrc (or
I-vsrc) to that from parallel cultures of yeast containing YEP 51
(or IP 51) are shown. Nwnbers that are vertically aligned in the
same OOX are fran experiments done on the same day.
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galactosidase expression directed by a promoter containing UAS2UPl is induced 5-6X by
lactate compared to glucose (Forsburg and Guarante, 1988). In contrast, in two
independently derived clones of yeast, containing RSVCAT integrated at the HIS3 locus
in opposite orientations, the CAT activity per J-lg of total yeast protein in glucose was
consistently greater than in lactate (Table 3).
Further, when FRSVCAT is used to transform BWG 1-7A and its derivatives
hap2-1 (Guarante, 1984) which is HAP2-, and BWG 1-7ALlhap3 (Olesen et al., 1987;
Hahn et al., 1988) which is HAP3-, the CAT activities in the 3 strains were 19.2, 12.8
and 16 respectively (% chloramphenicol acetylated/J-lg protein/min.). This too, is in
marked contrast to the 50 fold less activity seen with UAS2UPl-beta-gal constructs in
the HAP2- and HAP3- strains compared to BWG 1-7A (Forsburg and Guarante, 1988).
v-sre may stimulate expression from the RSV LTR in yeast.
It has been shown that when v-src is expressed in yeast it is myristylated, goes to
the plasma-membrane and has tyrosine kinase activity (Kornbluth et al., 1987; Brugge et
al., 1987). Since, in animal cells, v-src appears to stimulate transcription from the RSV
LTR using CCAAT boxes in the LTR, and since these same CCAAT boxes appear to
playa role in transcription from the LTR in yeast, it was of interest to examine if v-src
could induce expression from the RSV LTR in yeast e '
Over-expression of v-src in yeast has been demonstrated to be toxic (Kornbluth et
al., 1987; Brugge et al., 1987). Hence our strategy was to examine the effects of low lev­
els of v-src. Towards this end, Y-vsrc or the control vector YEP51 was introduced into
a strain of yeast harboring a single copy of RSVCAT at the HIS3 locus (RSVCAT-HIS).
As expected, changing the medium to one containing galactose caused a dramatic loss of
yeast proteins and CAT activity. However, even in media without galactose, the strain
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FIGURE 19.
Northern blot analysis of total RNA from yeast containing one copy of RSVCAT
integrated at the HIS3 locus (RSVCAT+HIS) and either IP 51 (lanes 1,2) or I-vsrc (lanes
3,4: clone K; lanes 5,6: clone L) at the LEU2 locus. 3xl07 yeast were inoculated into 20
ml of synthetic medium lacking histidine and leucine and with glucose as the sole carbon
source. After 24 hrs., the cultures were split, spun down, washed, and resuspended in
the same volumes of media containing either glucose (odd lanes) or galactose (even
lanes). RNA was harvested after 16 hrs., blotted and probed with nick-translated
RSVCAT. The major species of CAT RNA is shown. The lower panel shows the blot,
stained with ethidium-bromide, to demonstrate that equal quantities of RNA were
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containing Y-vsrc often showed a two-fold higher CAT activity than the one containing
the control vector (upper half of Table 4). Brugge et al. (1987) have shown that there is
leaky expression of v-src in yeast containing a plasmid analogous to Y-vsrc even in the
presence of glucose. On one particular day, the level of activity was lower in Y-vsrc con­
taining yeast compared to YEP 51 containing yeast, demonstrating that there is some
variability in the system.
An alternative way to produce v-src in low doses would be to express it from a sin­
gle copy integrated gene instead of a multicopy plasmid. The 2 uit: ARS was excised
from Y-vsrc and YEP 51 to give plasmids I-vsrc and IP 51. These were linearized at an
unique Cla I site in the selectable LEU2 gene and transfected into yeast containing one
copy of RSVCAT at the HIS3 locus (RSVCAT+HIS), which were then selected for
LEU+ phenotype. Several clones were grown under various conditions and CAT
activites measured to check if v-src had any stimulatory effect on expression from the
RSV LTR. The results presented in the lower half of Table 4 again suggest that under
one particular condition a stimulatory effect of v-src on the LTR may be discerned. The
requirement of growth in synthetic medium (as opposed to YEP medium) is obvious and
could be due to a difference in phosphate content between the two media.
In an effort to ensure that the 2 fold increase in CAT activity in the I-vsrc contain­
ing yeast was at the RNA level, the experiment presented in Fig. 19 was done. Growth
in galactose for 16 hrs. appears to suppress CAT RNA very strongly, but again it can be
seen that both the clones of yeast carrying I-vsrc contain about twice as much CAT
mRNA than the clone with vector alone. This difference is not seen when the same




The RSV LTR is recognized by the transcription machinery of S. cerevisiae.
There have been a few reports in the past of promoters from animal cells directing
transcription in yeast (Handa et al., 1985; Kornuc et al., 1988). However, this is the first
instance of (a) a retroviral promoter .directing transcription accurately in yeast and (b)
the same TATA box and upstream activating sequences being used in animal cells and in
yeast. The initiation of transcription about 60 bases downstream from the TATA box is
expected from the studies of Handa et al. (1985) who observed a similar phenomenon
when studying the initiation of transcription from the E1A promoter in S. cerevisiae.
The S1 nuclease assay shown by Kornuc et al. (1988) is suggestive of a shift of 40 bases
in the start-site of the adenovirus E3 promoter in yeast, compared to HELA cells (con­
trary to the conclusions of the authors).
How common is this phenomenon likely to be? If initiation of transcription in S.
cerevisiae requires only a TATA box, then it may be more likely than expected. The
situation may be complicated somewhat if there are multiple TATA box like sequences,
each recognizing a specific factor (Simon et al., 1988). It may be possible that some
TATA box factors are absent in yeast. There may also be complications produced by
sequences near the promoter fortuitously resembling binding sites of yeast DNA­
binding-proteins which might then interfere with transcription-initiation. It could be
concluded, however, that if one were interested in using genetic approaches to isolate
transcriptional factors that interact with a promoter, it is certainly worthwhile to check
the activity of the promoter in yeast.
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Are there multiple CCAAT box binding factors in yeast ?
There appear to be multiple CCAAT box binding factors in animal cells (Dorn et
al., 1987; Chodosh et al., 1988a; Hatamochi et al., 1988; Santoro et al., 1988; Paonessa et
al., 1988; Gil et al., 1988) making it likely that the same is true for yeast. The CCAAT
sequences in the RSV LTR behave as activating sequences in yeast, suggesting that they
may bind CCAAT box factors. . Possible candidates for such factors are the
HAP2/HAP3 encoded proteins (Chodosh et al., 1988b). However, the fact that lactate
does not induce the RSV LTR and that there is no significant decrease in LTR activity
in hap2- or hapd" yeast, makes it unlikely that HAP2/HAP3 play a significant role in
regulating transcription from the RSV LTR in S. cerevisiae. This, together with the
observations in the following section, opens up the possibility that there are other
CCAAT box binding factors in yeast.
Do the Ty elements of yeast use similar factors for dir-ect-ing transcription?
S. cerevisiae contain retrovirus like elements known as Ty elements that belong to
two classes Ty1 and Ty2. These have terminal delta sequences that are similar to the
LTRs of retroviruses. Mutational analysis has shown that transcription from these delta
elements require an intact TATA box, and an UAS located about 100 bases upstream
from the TATA box (Liao et al., 1987). Inspection of the UAS region reveals the pres­
ence of a CCACT sequence.
It has also been shown that transcription from the delta elements is influenced by
"internal enhancer sequences" situated in the "epsilon" region of the Ty element. One
of these sequences from Tyl, which has been found to confer 2.5 fold stimulation of
expression from heterologous promoters in haploid cells, and a fivefold repression in
a/alpha diploid cells is shown in Fig. 18. This same element shows sequence similarity
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to the al-alpha2 site of MAT alpha and could be involved in the repression of MAT
alpha in a/alpha diploid cells. This "Block II" region binds a protein present constitu­
tively in haploid and diploid cells, which fails to bind if there is a mutation that also
inactivates the "enhancer" like function of the sequence (Company and Errede, 1988).
As shown in Fig. 18, the "Block II" region contains a CCAAT motif and Company and
Errede (1988) have shown that mutations change either the CCAAT sequence or the
purine that is present 5 bases downstream from the CCAAT element inactivate the abil­
ity of the element to both bind the DNA binding protein and to act as an "enhancer" in
vivo. The significance of the purine in animal cells has already been discussed (Fig. 9).
Taken together, these observations underline the similarities between the Ty ele­
ments and the RSV LTR, and may explain why the LTR directs accurate initiation of
transcription in yeast, and even why the same sequence motifs for UAS function are
used that are used in mammalian cells.
Can this system be used to genetically define transcriptional factors that
interact with the RSV LTR ?
The presence of phenotypic changes in yeast that correlate with changes in the
strength of the RSV LTR (Fig. 17) makes the system amenable to genetic analysis. One
can also use RSVNEO to confer resistance to G418 in yeast (data not shown) thus
offering a second phenotype for screening for mutants with defects in the transcriptional
machinery as opposed to mutants with lesions in the CAT gene or steps in the uptake,
metabolism or action of chloramphenicol.
Further, a phenotype arising from absence of a TATA box or CCAAT box makes it
very easy to (a) test for activity of various TATA sequences or CCAAT sequences and
(b) test for the activities of factors binding to these sequences. For the CCAAT box
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binding factors, one can hope to define new factors in yeast, either by screening yeast for
mutants that have less activity from the RSV LTR, or by directly looking for yeast pro­
teins (or genes coding for such proteins) that bind to the CCAAT sequences in the RSV
LTR.
Does v-src stimulate expression from the RSV LTR in yeast?
The results presented in this chapter can best answer this question with a
"maybe". The twofold stimulation seen in some of the experiments may be significant,
particularly because the CCAAT boxes appear to stimulate RSV LTR activity only
about twofold in yeast (Fig. 16), as opposed to the tenfold stimulation by these same
CCAAT boxes seen in mammalian cells (Fig. 3). Further, a twofold difference in CAT
activity does give a difference in phenotype (Fig. 17) and should that be true in the case
of the v-src stimulation of the RSV LTR, then the system would lend itself to genetic
analysis.
The major weakness with this part of my thesis is that we have not been able to
demonstrate an induction of CAT activity on switching the yeast containing RSVCAT
and I-vsrc to a medium containing galactose (which would induce v-src). This may be
due to a suppressive effect galactose itself has on transcription from the RSV LTR
(Fig.21) in synthetic medium. In fact, within three hours of transferring yeast that carry
RSVCAT and IP 51 into a galactose containing synthetic medium, a 50 % drop in CAT
activity is seen. In YEP medium, in contrast, neither the suppressive effect of galactose
nor the "inducing" action of v-src can be seen. Another way of interpreting this would
have been that in synthetic medium, galactose represses the RSV LTR and v-src relieves
this repression partially. However, this is made unlikely by the observation in Table 4 of
a 2X stimulation of CAT activity by Y-vsrc in sugars other than galactose, namely, glu-
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cose and raffinose. Anyhow, should there be a phenotype produced by the action of v­
src on RSVCAT, it would be fruitful to look for mutations that interfere with the





In this chapter, I intend to discuss three issues not discussed earlier.
Is the effect of tyrosine kinases, including v-src, on a transcription factor likely
to involve a tyrosine-kinase-speeific pathway?
Two different cis-acting elements from the rat prolactin and the Moloney murine
leukemia virus promoters, which did not appear to bind a common factor, were both
able to transfer the transcriptional effects of EGF and TPA (Elsholtz et al., 1986). Like­
wise, Fisch et al. (1989) reported that an AP 1 binding site can mediate induction by
EGF and TPA. Both these results indicate that the action of tyrosine kinases on tran­
scription can (i) be mediated by different responsive elements and their binding factors,
and (ii) the same responsive elements and factors can be stimulated by serine kinases like
protein kinase C. This suggestion is reinforced by the observed convergence of several
inducing pathways on the short "serum response element" (SRE) of the c-fos promoter.
The SRE can mediate induction by agents like serum, EGF, and insulin on the one hand
and agents like TPA on the other (Treisman et al., 1985; Gilman et al., 1986; Fisch et
al., 1987; Greenberg et al., 1987; Stumpo et al., 1988). These observations imply that at
least two tyrosine-kinases (EGF receptor and insulin-receptor] utilize final effectors that
are common to TPA, which activates a serine kinase. Even among the serine-threonine
kinases, two different pathways involving either the cyclic AMP dependent protein
kinase or protein kinase C, appear to induce the same factor, namely AP2 (Imagawa et
al., 1987). All of these results indicate that there is significant overlap in several of the




A short sequence from the polyoma virus enhancer has been shown to confer indu­
cibility by TPA, serum, and a variety of transforming oncogenes including polyoma mid­
dle T, v-src and v- ras to a heterologous promoter (Imler et al., 1988; Wasylyk et al.,
1988). The sequence binds a mouse transcription factor, PEAl, though whether the
inducing agents change the activity of the factor is not yet known. PEAl is closely
related to API. Both of them drive transcription from promoters of tumor viruses, and
can confer responsiveness to a tyrosine kinase and to TPA (Angel et al., 1987; Lee et al.,
1987; and references cited in preceding paragraph). The similarities between PEAl/API
and the CCAAT box binding factor we have described are inescapable, and suggest that
the CCAAT factor which we find to be stimulated by tyrosine kinases, could also be
induced by TPA or cAMP.
Finally, the stimulation of transcription of the API gene by EGF (Quantin and
Breathnach, 1988) further illustrates the interplay of the tyrosine kinase induced path­
ways and other signal transduction pathways.
Having considered all of the above, it does seem that the nuclear effectors of tyro­
sine kinases are unlikely to to be tyrosine-kinase specific. In fact, the convergence of
tyrosine kinase pathways and those induced by protein kinase C might be more than a
co-incidence. It may well be that one acts through the other. Considering the subcellu­
lar localisation of most of the tyrosine kinases in the plasma membrane, and of several
serine kinases in the cytosol, e.g. the oncogene c-raf (Rapp et al., 1988), c-mos (Seth and
Vande Woude, 1988) and even protein kinase C (Farrar et al., 1985; however, also see
Nishizuka, 1988), it may be pertinent to suggest that the tyrosine kinases act by modu­
lating the actions of the cytosolic serine kinases.
There is some experimental evidence to support this conjecture. Though the
CCAAT box binding factor appears to be induced by tyrosine kinases, attempts to
 
- 72 -
deplete the factor from a nuclear extract using antiphosphotyrosine antibody were
unsuccessful (our unpublished results, with M. Hamaguchi). Further, when nuclear
extracts from 3Y1 cells and from HeLa cells were run out on a gel and immunoblotted
with antiphosphotyrosine antibody, we found no enrichment of any of the phosphotyro­
sine containing proteins in the nuclear extract compared to the cytosolic fraction. This
is consistent with the immunofluorescence data of Maher et al. (1985), who found most
of the phosphotyrosine containing proteins outside the nucleus. The DNA binding
activity of the "serum response factor" (SRF) which binds to the "serum response ele­
ment" (SRE) upstream of the c-fos promoter has been shown to be induced by EGF in
A431 cells (Prywes and Roeder, 1986) and yet, direct phosphoamino acid analysis of SRF
labeled with radioactive orthophosphate from A431 cells revealed phosphorylation on
serme and none on tyrosine (Prywes et al., 1988). All of the above would imply that
direct phosphorylation of transcription factors by tyrosine kinases (Migliaccio et al.,
1986; Auricchio et al., 1987) is more the exception than the rule. The phosphotyrosine
containing nuclear proteins isolated from Abelson transformed fibroblasts (Bell et al.,
1987) have been shown to bind to DNA and appear to have counterparts in RSV
transformed CEF and 3Yl. These proteins may turn out to be transcription factors but
there is no experimental evidence for this yet.
In contrast, there is plenty of evidence for the activity of transcription factors being
regulated by direct phosphorylation of the factors themselves (Sorger et al., 1987;
Hoeffler et al., 1988; Prywes et al., 1988; Sorger and Pelham, 1988), and in at least one
instance, the phosphorylation is on serine and not tyrosine (Prywes et al., 1988). LOike­
wise, there is ample evidence for transcriptional factors being activated by serine­
threonine kinases in the cell (Comb et aI., 1986; Sen and Baltimore, 1986; Imagawa et
al., 1987; Angel et al., 1987; Lee et al., 1987; Riabowol et al., 1988; Fisch et al., 1988;
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Hyman et al., 1989; Fisch et al., 1989;). Finally, at least some serine-threonine kinases
are known whose activity is stimulated by tyrosine kinases (Morrison et al., 1988; Stur­
gill et al., 1988). All of which might be construed to suggest that tyrosine kinases act
through serine-threonine kinases to modulate the activity of transcription factors.
There is some pharmacological evidence to support this point of view. Hall and
Stiles (1987) showed that depletion of protein kinase C from a cell by prolonged exposure
to TPA, blocked the induction of c-myc and c-fos by PDGF.
This line of reasoning is also supported by the fact that while v-ras transformed
cells and v-mos transformed cells are as serum-independent as cells transformed by
tyrosine-kinases like v-src, there is no increase in the levels of PTYR containing proteins
in the former (Mayer et al., 1988b) .
. Transport of proteins into the nucleus.
The incidental finding that serum causes a tenfold increase in extractable nuclear
proteins even in the presence of cycloheximide, points to protein import into the nucleus
(reviewed in Gerace and Burke, 1988) as an important step in the control of activity of
transcription factors. A basic stretch of amino acids has been identified as a nuclear
localization signal in several nuclear proteins. Furthermore, systems that carry out tran­
sport of nuclear proteins into the nucleus in vitro have been developed, and studies with
these have revealed that uptake by the nucleus involves a binding step which requires
the presence of the karyophilic signal mentioned above, followed by an ATP dependent
transport step (Newmeyer and Forbes, 1988). Hence, transport of transcriptional factors
into the nucleus could be a regulatable process.
Another possibility could be that transport into the nucleus is regulated by factors
In the cytosol which form complexes with the transcriptional factors and prevent their
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import into the nucleus. Such a mechanism may underly the post-translational activa­
tion of NFkB by TPA (Bauerle and Baltimore, 1988a and 1988b). It would be fascinat­
ing if some of the repressors identified genetically in S. cerevisiae, which appear to act by
binding to positively acting transcription factors, e.g. GAL 80 binding to GAL4 or PHO
80 and PHO 85 binding to PHO 4 (Oshima, 1982), are similar to IkB, which acts by
binding and inactivating NFkB in the cytosol of animal cells (Bauerle and Baltimore,
1988a, 1988b) because that would indicate that this mechanism of control is very
widespread, and open up another way to regulate the activity of transcription factors.
Signal transduction in Saccharomyces cerevisiae.
The homology of the transcriptional apparatus of yeast and animal cells has been
highlighted in the recent past (Chodosh et al., 1988b, 1989; Fodor et al., 1988; Cavallini
et al., 1988; Buratowski et al., 1988; Metzger et al., 1988; Webster et al., 1988;). A
natural question that arises from these observations is how 'homologous are the signal
transduction systems? Celenza and Carlson (1986) reported that derepression of a glu­
cose repressible gene, SUC2, requires the activity of SNF1, which codes for a serme
threonine kinase. SNF1 may be acting through a negative regulator, SSN6. Another
signal transduction system that has been studied in great detail has been the response to
mating factor. Here too, some genes that are essential for normal transduction of the
signal code for proteins with counterparts in animal cells. The receptors for the mating
factors, STE2 and STE3, resemble beta adrenergic receptors with seven hydrophobic
domains (Nakayama et al., 1985; Hagen et al., 1986). The pathway also utilizes a gene
coding for an alpha subunit of a G protein called SCG 1 or GPA1 (Dietzel and Kurj an,
1987; Nakafuku et al., 1987), and genes coding for beta and gamma subunits for G pro­
teins called STE4 and STE18 (Whiteway et al., 1989).
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In some instances where genes for DNA binding proteins have been cloned from
animal cells and introduced into yeast, they have retained their function. Of particular
interest is the ability of the human oestradiol receptor to activate gene expression in a
oestrogen dependent manner through' an oestrogen responsive element in yeast (Metzger
et al., 1988; Schena and Yamamoto, 1988) and the ability of the bovine papilloma viral
E2 trans-activator to activate transcription from E2 binding sites also in yeast (Lambert
et al., 1989). All of these findings made us examine more closely if the transcriptional
effects of the v-src tyrosine kinase could be analyzed in yeast. The results of these
experiment are discussed in chapter 4. Here I wish to address the phenotype of one par­
ticular clone of S. cerevisiae (called GOURI) expressing v-src under control of a GALlO
promoter (which is repressed by glucose, derepressed by raffinose, and induced by galac­
tose ).
GOURI had a growth-rate in YP-glucose and YP-raffinose that was approximately
the same as the clones containing vector alone (doubling time: 2 hrs.) but the saturation
density was 1/2 as much. However, in YP-raffinose and in YP-galactose, GOURI takes
on an elongated morphology reminiscent of "schmoos". It was possible that the growth
that was seen with GOURI in YP-raffinose was due to cells that shut down v-src expres­
sion. The experiments were repeated in synthetic medium with selection for the LEU+
phenotype (the v-src plasmid carries a LEU2 gene). Here the schmooing phenotype of
GOURI was more pronounced in galactose than in raffinose and was again not seen in
glucose. Growth in synthetic medium with raffinose was slow for GOURI (doubling time
: 4 hrs.), compared to that for clones with vector alone (doubling time : 2.3 hrs.) or
another clone expressing v-src (doubling time : 2.0 hrs.). The saturation density of
GOURI in synthetic medium with galactose was tenfold less than that of yeast with vec­
tor alone and half of that of other clones containing the integrated v-src plasmid.
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What does all this mean? Since, the phenotype of GOURI was not found in five
other clones containing l-vsrc, I conclude that GOURI has another mutation which
causes V-STC to confer the "schmooing" phenotype. It is likely that v-src has a role to
play in the phenotype, because of its induction by raffinose and galactose, but this has
to be proved genetically. Should this be the case, then GOURI may provide a novel
approach for studying the action of v-src in yeast. Particularly in light of G protein
involvement in the signal transduction of the pheromone response pathway (which does
produce schmoos), it is possible that the involvement of v-src in inducing the formation
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